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The efficacy of many biomedical therapies can be improved when the physical 
processes which underlie the treatment modality are thoroughly understood.  
Many treatments make use of transport processes that are deeply embedded in 
mechanical engineering theory and practice. The research documented in this 
thesis is firmly based on fluid-mechanic, heat-transfer, mass-transfer, and 
particle transport theory.  The thesis encompasses three categories of 
biomedical applications: drug distribution, thermal-based surgery, and drug 
delivery by means of particle transport. 
The first application dealt with a drug-eluting stent and with the distribution of the 
drug both into the artery wall by diffusion as well as into the blood flowing in the 
lumen via advection.  This conjugate problem was redefined in dimensionless 
form and solved by numerical simulation to yield universal solutions.  The 
solutions revealed the existence of a mass transfer boundary layer adjacent to 
the surface of the stent.  Upstream diffusion, opposite to the direction of the 
advection, occurred. The results showed that the mass transfer into the flowing 
blood was orders of magnitude larger than the diffusive transfer into the artery 
walls. 
The focus of the second application was an in-depth, a fundamentals-based 
investigation of a new, minimally invasive treatment for menorrhagia.   The 
involved physical processes include vapor transport into the uterine cavity, heat 
liberated by phase-change, and heat penetration into human tissue by means of 
conduction and blood perfusion.  Cell necrosis was achieved by elevated 
temperatures sustained for a sufficient period of time.   The outcome of this work 
was the depth of tissue necrosis corresponding to a given duration of the 




The final focus was the creation of a new methodology for the accurate delivery 
to targeted sites of drug particulates administered either through the mouth or the 
nose.  The drug particles are carried through the respiratory system by an air 
stream.  A numerical-based solution process was developed utilizing the laws of 
fluid mechanics, the physics of particle transport, and impaction theory.  The final 
solution proved capable of predicting the landing locations of particles based on 
their respective sizes. 
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CHAPTER 1 – INTRODUCTION AND MOTIVATIONS 
 
Many biomedical remedial devices can be studied and better understood by 
careful examination of the fundamental processes which drive the resultant 
therapy.  Many of these processes are some of the basic phenomena studied 
and explored in the field of mechanical engineering.  Biological functions such as 
respiration and the cardiovascular circulation system are defined by the transport 
processes of fluid dynamics.  Similarly, the use and delivery of drugs within the 
body are profoundly related to mass transfer and fluid dynamics.  Additionally 
there are various conditions and therapies that involve the transport of heat such 
as hyperthermia or hypothermia.  Thermally based therapies have replaced 
traditional surgery in numerous instances.  This brief review suggests a strong 
synergy between mechanical-engineering-based transport processes and 
biomedical functions and therapies. 
The use of numerical simulation as a modality for the quantification of complex 
physical processes has enabled competent predictions of biomedical responses 
to therapeutic actions.  Of special significance to this thesis is the heightened 
capability of software focused on fluid dynamics, heat transfer, mass transfer, 
and particle transport as they apply to mechanical engineering.  The key to the 
successful use of that software is the art and science of modeling.  Even with the 
increased capacity of computing equipment, total fidelity to real systems, 
especially those relevant to biological processes, is not yet possible. 
The mathematical descriptions of all the physical processes that are relevant to 
this thesis encompass non-linear, simultaneous, partial differential equations.  To 
the best knowledge of the author, only analogue computers are able to solve 
differential equations as such [1].  Digital computers are restricted to solving 
discretized forms of differential equations.  Discretization is a process by which 
differential equations are metamorphized to algebraic equations.  The three best-
2 
 
known methods to accomplish this transformation are finite-difference, finite-
element, and finite-volume.   Of these, finite-element discretization is favored for 
structural analysis, finite-volume is favored for fluid mechanics, heat transfer, and 
mass transfer, and the finite-difference is most often used in mathematically 
based derivations.  
In the discretized formulation, attention is focused on nodes and elements. The 
nodes are the selected points at which the numerical solution is to be obtained 
while the elements are volumes that fill the solution space.  Nodes are distributed 
on the boundaries of the elements.   
In an attempt to produce numerical simulations which more closely represent the 
actual physical processes, significantly higher nodal densities are employed to 
account for the many complex phenomena that often occur simultaneously.  The 
resultant nodal densities are required in order to accurately resolve the complex 
variabilities in fluid flow pattern such as boundary layer flow, recirculation zones, 
steep pressure gradients, continuously but abruptly varying flow cross-sectional 
area, flow direction reversals, etc.  In addition to these fluid flow intricacies, the 
current physical processes of interest contain heat transfer, mass flow, phase 
change, particle-capture modalities, and mechanical-device-driven flows.  It is 
imperative to consider each of these phenomena when designing the mesh for 
the simulation as each of these processes may be more or less complex in 
specific zones.  One zone may have a relatively simple fluid flow pattern, but the 
heat transfer or phase change in that zone may require elevated nodal densities 
to get the best solution from the simulation. 
The overarching theme of this thesis research is biomedical therapeutic 
processes delivered by fluid-mechanic means.  The specific applications all 
relate to fluid flow, but are otherwise unique within themselves.  In one 
therapeutic application, the focus is directed to the migration of a drug substance 
from its zone of application to downstream locations under the dual action of 
advection and diffusion.  In a second situation, a delivered medium undergoes a 
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phase change which produces thermal energy whose action is to elevate tissue 
temperatures and cause necrosis.  The last of the applications is concerned with 
trajectories of medications in the form of particulates that are transported to their 
target locations through the respiratory system.  Each of these applications 
requires unique modeling.  The models involved present a kaleidoscope of 
different physical processes and phenomena.   
The specifics of these applications will be dealt with serially.  The relevant 
literature for each of the specific applications will be cited in the introduction 
section of the respective chapters in which the application is described. 
The first application relates to drug-eluting stents.  In general, a stent is a 
structure whose function is to maintain an artery as an open cross section for the 
flow of blood.  This function is a necessary follow-on of a procedure called 
angioplasty.  That procedure is employed when arteries become blocked by the 
deposition of plaque; plaque-blocked arteries are frequently termed stenosed.  
To return the artery to its proper function, the first step is to open the blockage.  
Although logic suggests that the opening of the blockage should be, somehow, 
related to the removal of the plaque, that is an uncommon event.  In reality, a 
balloon, whose initial state is flaccid, is maneuvered through the cardiovascular 
system by means of a guide wire or a catheter and then brought to rest in a 
stenosed artery.  Subsequently, the balloon is inflated, thereby pushing back the 
stenosed walls and opening the artery cross section.  Experience has taught that 
that opening will not maintain itself.  Consequently, a place holder made of a 
structurally strong medium is delivered to the site, again by means of a guide 
wire or catheter.  A common configuration for the placeholder is a wireframe, 
termed a stent. 
Since the stent is an intrusion into a biologically sensitive environment, it has 
been found that acceptance of the stent by the body is enhanced by coating the 
stent wireframe by a drug, for example, paclitaxel.  The drug is encased in a 
polymer envelope.  Upon placement of the stent, the drug diffuses through the 
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polymer and is dispersed, partially into the plaque and therefrom into the artery 
wall.  In addition, some of the drug mingles with the flowing blood and is 
advected downstream.  Owing to cross-stream diffusion, some of the advected 
drug is delivered to the downstream artery walls, and diffuses into them.  The 
penetration of the drug into the artery wall at downstream locations is the focus of 
Chapter Two of this document. 
The second application, addressed in Chapter Three, entails the study of an 
alternative therapeutic approach to treating menorrhagia which utilizes heat 
liberated from steam condensing on the uterine walls.  There are many reasons 
for finding new, non-surgical, therapies for treating this condition that minimize 
the need for removing the uterus, a procedure known as a hysterectomy.  There 
are several treatment options that involve the use of heat to achieve necrosis of 
the tissue [2].  If the heat source can be well controlled, both in temperature and 
spatial uniformity, it gives the patient a viable alternative to surgery.  The process 
studied in this work utilizes steam as the heat source.  As steam enters the cavity 
and comes into contact with the uterine walls, which are at a relatively colder 
temperature.  The steam condenses and liberates a large quantity of latent heat.  
This heat then transfers into the tissue and begins to accumulate damage.  The 
elevated temperatures are considered along with the duration of time to calculate 
the Henriques-Moritz damage integral, a widely accepted method of evaluating 
tissue damage.  It is important to consider that tissue damage continues after the 
active application of steam, and this has significant impact on the depths of 
necrosis which result from the treatment. 
The third treatment of interest involves delivering a drug that enters the 
respiratory system by inhalation through the nose or mouth and provides the 
motivation for Chapter Four.  These drugs are often administered in extremely 
small liquid or solid particles, on the order of 10-6 m in diameter, from a nebulizer 
and are used to treat many different conditions.  An important element in 
maximizing the efficacy of the drug is being able to predict where it will be 
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deposited once it enters the human respiratory system.  If significant amounts of 
drug mass do not make it to the intended target, the treatment will have a greatly 
diminished effect.  The drug particles are carried through the respiratory system 
by the air flow patterns that occur in the passageways.  The flow path from the 
nose or mouth, through the throat and into the lungs is one of great complexity, 
encompassing many twists, turns, and changes in diameter along the way.  The 
travel path of particles of this size is heavily influenced not only by the size and 
density of the particles, but also the fluid velocity and the geometry of the flow 
path.   
To the best knowledge of the author, based on an exhaustive literature search, a 
methodology has yet to be developed to predict the trajectory of very small 
particles carried through an extremely complex flow path by a discrete rush of air.  
It is well understood that the geometry of the respiratory system is not only 
complex, but also differs among individuals based on age, gender, and physical 
condition, among other factors.  In this light, the task undertaken here is not 
specific to any of these categories.  Rather, the development is carried out for a 
geometry of sufficient complexity to ensure the applicability of the developed 
methodology to a variety of complex geometries. 
Therefore, the focus of the work is the methodology development.  To provide a 
quantitative means of identifying where particles of different sizes are collected at 
different locations, a model of a series of particle-collection impaction modules 
has been utilized.  The efficacy of the modeled system will be quantified with 





CHAPTER 2 – MASS TRANSFER BY ADVECTION AND 
DIFFUSION FROM A DRUG-ELUTING STENT 
INTRODUCTION 
The use of cardiovascular stents has become an accepted medical procedure for 
maintaining the lumen in an open state after the angioplasty procedure has been 
used to unblock a stenosed artery.  Early experience with the use of 
cardiovascular stents provided information about the body’s acceptance of the 
stent.  Furthermore, it was found that the presence of a stent could be a source 
of tissue damage in many cases.  To deal with these issues, the use of drug-
coated stents has been found to be effective.  In practice, the drug is cocooned 
within a polymer.  Mass transfer driven by concentration differences causes the 
drug to diffuse through the polymer.  Subsequent to this diffusion process, the 
drug may be carried away by the blood passing through the lumen or may diffuse 
through the tissue layers that form the artery wall. 
The distribution of the drug subsequent to its passage through the polymer has 
recently evoked considerable interest in the biomedical community.  The first 
paper dealing with the distribution of the drug among the tissue layers of the 
artery wall and the transport of the drug by blood flow in the lumen was published 
in 2007 [3].  Subsequent publications appeared in 2009 [4] and 2010 [5].  These 
papers can be characterized as having a common approach.  Each of them dealt 
with a specific case without recognition of the cases treated in the other papers.  
Earlier publications were focused on either the transport of the drug through the 
artery wall or into the blood flowing through the lumen but did not consider 
simultaneous transport. 
Among the previous work that dealt with transport of the drug through the artery 
wall, a variety of models were employed.  Three of these references formulated 
the problem in dimensionless form, but were based on primitive models.  In [6], a 
model taking account of diffusion and of spatially independent velocity was 
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adopted without description of the process by which the velocity was created.  In 
contrast, [7] is confined to a pure mass diffusion model.  The approach of [8] is to 
treat the mass diffusion problem as an analogous heat conduction problem. 
Other papers that are focused on drug diffusion through the artery wall dealt with 
specific values of the relevant parameters.  A common denominator among the 
wall-focused transport approach was the use of a porous medium model [9-11].  
In [12-13], the effect of compression of the artery wall was considered, while in 
[14, 15], the model included both diffusion through the polymeric coating and the 
arterial tissue.  The case of drug transport by means of lumen blood flow is 
treated in [16] by a boundary layer model. 
In the present work, the problem of drug transport both into the arterial wall and 
by the blood stream passing through the lumen is considered.  The special 
feature of the present approach is to recast all of the governing equations and 
boundary conditions in dimensionless form and to investigate a broad range of 
the governing dimensionless parameters.  This approach is a broad 
generalization of the limited previous work [3-5] to cover all of the possible cases 
that may occur in practice.  The previous work may be regarded as special cases 
of the work performed here. 
PHYSICAL MODEL 
The description of the physical model is facilitated by reference to Figure 2.1.  
The figure shows a sideview of an axisymmetric artery in which a drug-eluting 
stent has been put in place.  Although the stent is a ring which spans the entire 
circumference, in this view the stent appears as the darkened segments on the 
inner wall of the lumen.  Dashed lines have been used to represent the ring-like 
geometry of the stent.  The thickness of the stent is regarded as being very small 
compared with the thickness of the artery wall.  The surface of the stent is coated 




Figure 2.1 - Schematic side-view diagram of the physical system to be 
investigated. 
The dimensions and coordinates that are called out in the figure are all non-
dimensional.  The radius of the lumen is the representative length chosen for the 
non-dimensionalization.  Consequently, the dimensionless radius is one.  As can 
be seen from the figure, the solution domain starts at a distance of 10 radii 
upstream of the stent and extends to a distance of 60 radii downstream.  The 
stent itself has a streamwise length of two radii, and the thickness of the artery 













The mathematical model is conveniently described by using dimensionless 
variables.  In the definition of these variables, reference quantities are needed for 
the velocities, coordinates, lengths, and pressure.  These reference quantities 
are respectably, the mean velocity U’, the internal radius of the lumen R’, and the 
velocity head (ρ’U’2).  The physical variables will be distinguished by primes so 
that the dimensionless variables will be unprimed.  The definitions of the 
dimensionless variables are 
 
x’ = xR’, y’ = yR’, z’ = zR’, r’ = rR’ (2.1) 
u’ = uU’, v’ = vU’, w’ = wU’ (2.2) 
p’ = p(ρ’U’2) (2.3) 
Re = (ρ’U’R’)/µ’ (2.4) 
 
Note that the Reynolds number Re is based on the internal radius of the lumen. 
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Note that in these equations, the density ρ and the viscosity µ do not appear.  
Instead, in the position normally occupied by ρ in these equations, the coefficient 
1 appears.  By the same token, the position of µ as a multiplier of the viscous 
terms is now occupied by 1/Re.  Therefore, for all fluids that are to be 
considered, it will be appropriate to set the density equal to one and the viscosity 
equal to 1/Re.  This formulation enables the attainment of universal solutions. 
There are two equations needed to represent the conservation of mass in the 
flowing fluid.  One of these two equations is for conserving blood, the carrier fluid, 
and the other equation is for conserving the drug.  Alternatively, mass may be 
conserved for the mixture as a whole, and a separate conservation equation may 
be written for the drug.  The second of these alternatives is the one that is more 
commonly used in analysis.  For the mixture as a whole, dimensionless mass 









   (2.8) 
For the conservation of the drug as a species, note must be taken of the two 
processes by which the drug is transported.  One of these is the advective 
transport of a species by the bulk motion of the fluid, and the other is the 
transport by molecular diffusion.  The corresponding dimensionless species 















   
   
 
   
   
 
   





In this equation, the quantity c is the dimensionless concentration of the drug and 
Pe is the Peclet number, which are respectively defined as 
  
  
   




     
 (2.10) 
where c0’ is the given concentration of the drug at the surface of the stent; Sc, ν’, 
and  ’fluid are respectively the Schmidt number, kinematic viscosity, and the 
binary diffusion coefficient, all for the fluid mixture. 
The present model does not take account of convective motion in the artery wall, 
so that diffusion is the sole means of mass transfer.  Therefore, the governing 
equation for mass transfer in the wall reduces to 
[
   
   
 
   
   
 
   
   




 BOUNDARY CONDITIONS 
In the model adopted here, the stent is envisioned as a very thin ring whose 
infacing (lumen-facing) surface is at the concentration c0’.  The outfacing surface 
of the stent is in perfect contact with the artery wall.  The stent has a radius R, 
equal to that of the lumen, and has a streamwise length that is 2R.  With regard 
to the artery wall, it extends upstream and downstream from the stent by 10 and 
60 radii, respectively.  These dimensions define the solution domain in which the 
problem is solved.  At the inlet of the solution domain (x = -10), the velocity 
distribution in the lumen is parabolic and steady, and the concentration of the 
drug is zero both in the lumen and in the artery tissue. 
The downstream end of the fluid portion of the solution domain is defined by very 
weak boundary conditions which are, specifically, that the streamwise second 
derivatives are zero for all the velocity components and the concentration.  
Experience has taught that the specification of these weak boundary conditions 
provides ample freedom for the fluid flow and mass transfer to be very lightly 
constrained.  The other fluid-flow boundary condition at the downstream end of 
the solution domain is a prescribed pressure, which is here taken to be zero 
(gauge pressure).  The downstream end of the artery wall is defined by a no-
mass-flow boundary condition.  In addition, the artery wall imposes a no-slip 
condition on the tangential component of the velocity and an impermeability 
condition for the normal component of the velocity. 
The mass transfer boundary conditions at the upstream and downstream ends of 
the solution domain have already been discussed, as has the assigned uniform 
concentration at the lumen-facing surface of the stent.  It remains to deal with the 
concentration boundary conditions at the interface between the lumen and the 
tissue which comprises the artery wall.  Also needed is a boundary condition at 
the rear face of the artery wall.  At the lumen-tissue interface, continuity of mass 
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A second condition at the interface representing a discrete interfacial resistance 
was taken from [4].  It is 
(  
   
   
)
     
  (  
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= hm’ (c’tissue – c’fluid) (2.13) 
In these equations,  ’ is the mass diffusion coefficient, and (1/hm’) is the discrete 
resistance.  The quantities c’tissue and c’fluid correspond, respectively, to the 
concentrations of the drug on either side of the discrete resistance.  There is a 
jump of concentration equal to the difference between these concentrations.  At 
any arbitrary streamwise location, both c’tissue and c’fluid are unknown.  However, 
at the stent, c’fluid = c0’. 
To facilitate a numerical solution of the governing equations, it is appropriate to 
rephrase the physical boundary conditions in mathematical and dimensionless 
terms. 
(a) At the upstream end of the solution domain 
   (    )      (2.14) 
for the lumen, and c = 0 in the artery wall. 
(b)  At the surface of the lumen at all streamwise locations 
            (2.15a) 





     
 
       





      
  (2.15b) 







     






     
 (2.15d) 
The quantity Γ is a dimensionless group which resembles the Biot number for 
heat transfer. 
(c)  At the lumen wall and at the location of the stent, 0 ≤ x ≤ 2, 






     
  (         )  (2.16b) 
(d) The downstream closure for the fluid at x = 62 is 
   
   
 
   
   
 
   
   
 
   
   
     (2.17a) 
and in the artery wall 
  
  
   (2.17b) 
(e) At the back face of the artery wall 
  
  





 NUMERICAL SIMULATION 
The governing differential equations and boundary conditions were discretized 
and solved numerically by CFX software.  The discretization is performed by the 
finite-volume approach.  Although the problem, as formulated here, is 
axisymmetric, CFX does not have an axisymmetric option.  Therefore, it is 
necessary to create a three-dimensional version of the two-dimensional 
axisymmetric situation.  This geometric extension is achieved by creating a 
wedge of very small opening angle whose radial sides are symmetry planes and 
whose rim is an arc of the artery wall.  A schematic diagram of the wedge 
geometry is displayed in Figure 2.2.  The wedge angle that was selected for the 
solution is 2°. 
 
                    
Figure 2.2 - Wedge of small opening angle representing a symmetry module. 
The flow was regarded as laminar.  The discretization of the solution domain 
gave rise to a mesh encompassing 344,613 nodes and 170,500 elements.  Mesh 
independence calculations were performed by redeployment of the nodes so as 
to create a much more dense mesh in the near neighborhood of the wall.  The 
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two investigated meshes gave rise to wall mass transfer results that agreed to 
within 0.2%.  The surface mesh of the solution domain is exhibited in Figures 2.3 
and 2.4.  It can be seen from the figure that a graduated mesh was used 
adjacent to the lumen-tissue interface with particular concentration of elements in 
the neighborhood of the stent 
 
 
Figure 2.3 – Mesh used for the numerical solutions.  The darker areas illustrate 
the areas of significantly higher mesh densities. 
 
 
Figure 2.4 -  Mesh used for the numerical solutions.  The dark horizontal line is 






Region of stent Downstream Upstream 
One edge of stent 
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RESULTS AND DISCUSSION 
The first set of results to be presented is the rate of mass transfer from the 
medicated stent to the flowing fluid.  The local mass flux  ̇ at the infacing surface 
of the stent is given by Fick’s Law, which is 
 ̇          
   
   
 (2.19) 
The derivative is taken at r’ = R.  With the introduction of the dimensionless 
variables and coordinates, Eq. (2.19) becomes 
(
 ̇




)  [ ( )]         (2.20) 
where Re is the Reynolds number.  In this equation, f(x) represents a 
dimensionless derivative taken from the numerical solutions.  Its value depends 
on Re, Sc, and the other parameters that appear in Eq. (2.15).  If ( ̇   
 ) is 
regarded as a local mass transfer coefficient, then the left-hand side of Eq. (2.20) 
is similar to a local Sherwood number with the kinematic viscosity replacing the 
mass diffusion coefficient. 
The average mass flux  ̇ passing from the surface of the stent to the lumen fluid 
can be obtained by integration of Eq. (2.20), with the result 
(
 ̇




)      (2.21) 
where g depends on the Reynolds number Re and the Schmidt number Sc. 
Attention will next be turned to the numerical results and parametric 
dependencies of the average mass flux passing from the stent to the lumen fluid 
as given by Eq. (2.21).  The role of the Biot-number-like parameter Γ of Eq. 
(2.15d) was first investigated.  Values of Γ between 0.000008 and 100 were 
assigned for Re between 25 and 500 and for Sc between 2000 and 200000.  It 
was found that ̇  was completely insensitive to Γ.  Next, the ratio of the diffusion 
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coefficients that appear on the right-hand side of Eq. (2.15b) was assigned a 
fixed value of 0.0511 [4]. 
The final solutions yielding  ̇ were performed for Re values between 25 and 500 
and for Sc between 2000 and 200,000.  Power-law fits of high accuracy provided 
the compact representation 
(
 ̇








   
) (
 
      
)        (    )    (2.23) 
The compactness, simplicity, and generality of this result are witnesses for its 
usefulness. 
The results for the local mass transfer rates passing from the inward-facing 
surface of the medicated stent to the lumen are presented in Figs. 2.5(a-d).  In 
each figure, the dimensionless local mass transfer rate which appears on the left-
hand side of Eq. (2.20) is plotted as a function of the dimensionless axial 
coordinate   in the range      .  Each figure encompasses a main portion 
and an inset.  The main portion provides results for   between -0.02 and 0.1, 
while the inset spans the entire range between 0 and 2.  The reason for this dual 
presentation is to provide detailed results at the forward edge of the stent as well 
as results for the stent’s entire streamwise length.  Each figure corresponds to a 
discrete Reynolds number between 25 and 500. 
An overview of Figs. 2.5 reveals certain trends that are consistent among all of 
the figures.  The most apparent of these is that the highest rates of mass transfer 
occur in the neighborhood of the upstream edge of the stent.  In all cases, there 
is evidence of diffusive mass transfer carrying the drug upstream of the leading 
edge of the stent.  The high mass transfer peak decreases very sharply and for 
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most of the length of the stent, the mass transfer rates are a small fraction of the 
maximum.  Another very strong trend is the increase of the rate of mass transfer 
with increasing values of the Reynolds number.  This trend is readily identified by 
observing the mass transfer maxima at each of the Reynolds numbers.  These 
maxima are approximately 0.3, 0.45, 0.55 and 0.68, respectively for Re = 25, 
112, 250 and 500.  The effect of Reynolds number pervades the results over the 
entire longitudinal extent of the stent. 
Also strongly in evidence is the effect of the Schmidt number.  The rate of mass 
transfer diminishes sharply with increasing Schmidt number.  This characteristic 
can be attributed to the fact that mass transfer increases as the diffusion 
coefficient increases.  Since the diffusion coefficient appears in the denominator 
of the Schmidt number, the trend is entirely plausible.  Quantitative evidence of 
the Schmidt number effect can be obtained by comparing the peak values of the 
mass transfer rate at various Schmidt numbers.  For example, for Re = 25, the 
successive peaks in the mass transfer rate are approximately 0.3, 0.05 and 0.01 
as the Schmidt number is varied from 2000 to 20,000 to 200,000.  For Re = 500, 





Figure 2.5(a) - Local mass transfer rates from the inward facing surface of the 
stent to the lumen, Re = 25. 
 
Figure 2.5(b) - Local mass transfer rates from the inward facing surface of the 
stent to the lumen, Re = 112. 











Figure 2.5(c) - Local mass transfer rates from the inward facing surface of the 
stent to the lumen, Re = 250. 
 
Figure 2.5(d) – Local mass transfer rates from the inward facing surface of the 
stent to the lumen, Re = 500. 











The local mass flux from the outward-facing surface of the stent to the tissue is 
exhibited in Figs. 2.6(a) and 2.6(b).  Two figures are sufficient to convey these 
results since they are virtually independent of the Reynolds number.  Figures 
2.6(a) and 2.6(b) respectively correspond to Reynolds numbers of 112 and 500.  
A careful examination of the ordinate values of these figures indicates that the 
difference in the mass transfer rates at the two Reynolds numbers is of no 
practical significance. 
It is useful to compare the mass transfer rates to the lumen and to the tissue.  
From a comparison of Figs. 2.5 and 2.6, it is seen that the mass transfer to the 
lumen flow considerably exceeds that to the tissue.  It may, therefore, be 
concluded that a major part of the drug is not fulfilling its intended purpose.  
Another point of difference between Figs. 2.5 and 2.6 is the behavior upstream of 
the leading edge of the stent.  Figures 2.6 show that the drug is actually flowing 
from the wall into the lumen in the upstream region.  This process can be 
explained by noting that diffusion occurs in all directions, so that drug that enters 
the wall that is contact with the stent is able to diffuse within the wall to locations 
where x < 0.  At those locations, the concentration of drug within the wall is 
greater than that in the lumen, thereby giving rise to an outflow of the drug from 
the wall to the lumen.  The magnitude of this outflow is too small to be seen 




Figure 2.6(a) – Local mass transfer rates from the outward facing surface of the 
stent to the tissue, Re = 112. 
  
Figure 2.6(b) – Local mass transfer rates from the outward facing surface of the 
stent to the tissue, Re = 500. 











The transport of a drug from the surfaces of a medicated stent to blood flowing in 
the adjacent lumen and to the artery wall that contacts the stent has been 
determined by means of numerical simulation.  The physical processes 
encompassed by the model are fluid flow and advective/diffusive mass transfer in 
the lumen, diffusive mass transfer in the artery wall, and interfacial mass transfer 
resistance at the lumen-wall interface.  Previous work in the field had been 
restricted to special cases characterized by specific numerical values of the 
relevant parameters.  The present formulation is based on dimensionless 
variables and parameters with Reynolds number, Schmidt number, and a mass-
transfer Biot number as parametric groupings.  The dependent dimensionless 
grouping is a Sherwood number. 
A wide range of numerical values, spanning all realistic conditions, was assigned 
to the parametric groupings.  It was found that the Sherwood number results 
were not affected by the mass-transfer Biot number, thereby eliminating the 
interfacial resistance from further consideration.  If the Sherwood number were to 
encompass the mass diffusion coefficient, as is conventional, then the average 
Sherwood number for the mass flux from the stent to the lumen flow was found to 
depend on the product of the Reynolds and Schmidt numbers to the one-third 
power. 
The local mass transfer rates from the stent to both the lumen flow and to the 
contiguous artery wall were greatest near the forward edge of the stent.  The 
lumen-side results depended on the Reynolds number, while the wall-side results 





CHAPTER 3 – A UTERINE TISSUE ABLATION MODEL AND 
ITS IMPLEMENTATION 
INTRODUCTION AND BACKGROUND 
Menorrhagia, or Hematomunia, is a condition that results in abnormally heavy 
bleeding during regular menstrual cycles.  This condition is typically used to 
describe bleeding that lasts longer than seven days, or produces greater than 80 
mL of blood [17].  The condition affects more than ten million American women 
each year. In many cases, the direct cause for Menorrhagia is not known.  Some 
of the potential causes include hormonal imbalance, uterine fibroids, dysfunction 
of the ovaries, or the development of polyps. 
There is a wide variety of treatment options for Menorrhagia.  The selection of 
the treatment will depend on many factors including the cause for the condition, 
the woman’s age, general health condition, and medical history.  Some women 
find relief from drug treatments such as ibuprofen, iron supplements or hormone 
therapy, but this approach is not curative.  More curative approaches include 
surgical treatments such as dilation and curettage, operative hysteroscopy, 
endometrial ablation, or hysterectomy.  The most permanent of these treatment 
options is hysterectomy.  During this procedure, the uterus is partially or 
completely removed.  The procedure results in the patient being unable to 
conceive a child, and also has surgical procedural risks.  As a result of these 
effects, most women leave the hysterectomy as only the final option.  
A schematic diagram showing the different extents of the hysterectomy 
procedure.  The normal extraction of tissue material is defined by the orange 
long-dashed line shown in Figure 3.1.  A more radical extraction is also illustrated 




Figure 3.1 – Diagram depicting different extents of hysterectomy procedures 
 
Ablation of endometrium that constitutes the inner lining of the uterine cavity has 
gained acceptance as a means for remediation of menorrhagia.  An effective 
means for achieving this outcome is to impose elevated temperatures on the 
endometrial tissue for a duration of time that is sufficient to bring about cell 
necrosis.  In addition to the means to achieve the necessary temperature level 
previously discussed, a new method of the injection of elevated-temperature 
fluids into the uterine cavity is considered in this work.  A candidate fluid of 
considerable promise is steam (water vapor).  Its unique feature is the high 
concentration of thermal energy that is characteristic of the vapor phase.  The 
easy extraction of the concentrated thermal energy by means of condensation 
enables high rates of heat transfer to be applied to the walls of the uterine cavity.  
In this study, detailed numerical simulations are used to evaluate the duration of 
time required to achieve the desired depths of necrosis.  Attention is also given to 
the uniformity of the depth of necrosis along the uterine lining. 
There are several procedural options for removing the localized effected tissue, 
categorized as endometrial ablation.  Cryotherapy is a treatment that uses low 
temperatures to achieve the desired necrosis.  At the temperatures utilized in this 
procedure, on the order of -100°C, the tissue fluids freeze.  Since these fluids are 
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water-based, they expand during the phase change from liquid to solid.  This 
procedure is implemented by causing the tip of a small probe, which is inserted 
into the uterus, to attain the desired temperatures.  The probe is guided to its 
target location by means of ultrasonic imagery.  The probe tip is cooled by either 
flowing liquid nitrogen through it, or by expanding a compressed gas, causing the 
localized temperature reduction. 
 
Figure 3.2 – Illustration of implementation of cryosurgical necrosis of 
dysfunctional tissue. 
 
In its present utilization, cryosurgical implementation is based on the usage of 
gases such as argon, nitrous oxide and carbon dioxide [2].  These gases become 
cryo media due to the Joule-Thomson effect.  This effect occurs when the gas 
flows adiabatically in a capillary tube of very small diameter.  The concomitant 
pressure drop (of the order of a factor of seven) initializes the effect.  An ideal 
gas is immune from the Joule-Thomson effect, but it is well known that there are 
certain ranges of pressures and temperatures within which almost all gases 
relinquish ideal gas behavior.  The setup for the implementation of argon-based 
cryosurgery is shown schematically in Figure 3.3.  As seen there, argon, 
contained in a high pressure container, flows through a capillary tube where it 
experiences a pressure drop large enough to activate the Joule-Thomson effect.  
The proximal end of the capillary tube is open, and the low temperature argon 
gas expands into an enlarged space.  The rapid expansion induces shock waves 
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(not shown in the diagram).  After the expansion, the flow turns sharply and 
enters an annular space which conveys it to exit ports. 
 
Figure 3.3 – Setup of the apparatus for the application of cryosurgery involving 
argon. 
 
An alternative to the cryo-based ablation, there are a number of procedures 
based on the use of elevated temperatures.  The temperature elevation may be 
achieved by electrocautery, hydrothermal pumping, balloon therapy, 
radiofrequency and microwave ablation, and the new methodology to be 
assessed in detail in this work.  To implement electrocautery, an electric current 
passes through a wire loop or rollerball that is applied to the endometrial lining to 
cauterize the tissue [18].  The implementation of this therapy is illustrated in 




Figure 3.4 – Application of electrocautery by means of a rollerball. 
 
The hydrothermal procedure is based on heated fluid being pumped into the 
uterine cavity to destroy the endometrial lining [2]. This procedure is illustrated in 
Figure 3.5.  
 




For balloon therapy, a balloon at the end of a catheter is inserted into the uterus 
and filled with a fluid (liquid or gas) which has been heated to temperatures that 
cause tissue necrosis.  The execution of this approach is shown schematically in 
Figure 3.6.  The figure shows the balloon in intimate contact with the endometrial 
lining. 
 
Figure 3.6 – Implementation of balloon therapy.  [20] 
To accomplish radiofrequency ablation, a triangular mesh electrode is expanded 
to fill the uterine cavity. The electrode delivers electrical current and destroys the 
endometrial lining [2, 21].  A diagram, Figure 3.7, illustrates the general approach 
which is widely used for thermally based alternatives to scalpel-based surgery.  
The electromagnetic energy is converted to thermal energy. 
  




Microwave heating is based on the same principle as radiofrequency heating.  
The implementation of microwave ablation is the delivery of microwave energy 
through a slender probe that has been inserted into the uterus and destroys the 
endometrial lining [2, 22-24].  Figure 3.8 illustrates the mode of application of this 
heating methodology. 
 





METRICS FOR QUANTIFYING ELEVATED-TEMPERATURE 
TREATMENT MODALITIES 
The goal of any of the aforementioned procedures is to cause enough damage to 
the subject tissue to kill the cells, or otherwise referred to as achieving necrosis.  
Collagen is in high abundance and is, therefore, assumed to be one of the main 
proteins that are involved with thermal damage at these higher temperatures.  
The typical thermal damage process is protein denaturation that follows a first-
order chemical reaction.  It is well-established that the conditions that bring about 
cell necrosis involve both the temperature level and the length of time over which 
the temperature is applied.  The amount of time required to reach necrosis varies 
inversely to the temperature that is used.  Higher treatment temperatures will 
achieve necrosis faster than lower treatment temperatures.   
Generally, elevated-temperature thermal-based treatments are subdivided into 
two groups with respect to the targeted tissue temperature.  Tissue temperatures 
above 50°C are reserved for direct treatment, and the therapy is termed ablation.  
When the target temperatures are between 40 and 45°C, the term hyperthermia 
is used to describe the therapy [25, 26].  
 
Ablation therapy relies on the direct cytotoxic effect of temperature elevation.  
This mechanism of cell death is related to denaturing both functional and 
structural proteins (intra and extra cellular) [26].  The major extra-cellular 
structural protein constituent is collagen of various types, all with similar 
sensitivities to thermal injury [27, 28].  Thermal denaturation of collagen is a high-
temperature metric of severe thermal damage and represents an upper-bound 
target process in ablation treatments that, when reached, is a sure sign of cellular 
death and severe vascular disruption.   
 
Hyperthermia-based therapies rely on elevating the tissue temperature to 
relatively noncytotoxic levels to alter the local physiological environment and/or 
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cellular functions in a way that enhances other treatments.  The details of these 
changes are extensive and have been reviewed elsewhere [25, 26, 29, 30].  The 
dominant physiological changes involve improved blood flow and oxygenation, 
stimulation of immune cell migration, and increased vascular permeability.   
 
Independent of the heating method used, standardized metrics are needed to 
quantify dosage requirements to achieve desired outcomes.  This is particularly 
important when comparing results from different studies, quantifying tissue-
dependent sensitivities to heat, or attempting to repeat studies for the purpose 
therapeutic implementation.   Two methods have come into general use for 
quantifying the deposited thermal energy.  The ablation community often uses 
the damage index, whereas the hyperthermia community typically uses 
cumulative equivalent minutes at 43°C, or the CEM°43 method [26, 30, 31]. Both 
the damage index and CEM°43 methods are based on the underlying premise 
that tissue damage follows an irreversible first-order chemical reaction with the 
rate constant following the Arrhenius relationship.   Despite this commonality, the 
two methods are used differently: one to predict the degree of necrosis and the 




Cumulative equivalent minutes of thermal treatment at 43°C (CEM°43) (first 
proposed by Sapareto and  ewey [31]) is commonly used as a standard in the 
hyperthermia literature to compare different thermal treatment histories to an 
equivalent heating time at 43 degrees C.  This procedure is discussed in depth in 
[26, 30].  Although the analysis is based on the assumption that thermal damage 
follows an irreversible first-order chemical reaction, experimental data have 
demonstrated that observed damage is approximately linear with temperature 
over a narrow range.  Additionally, the dose response curve has inflection points 
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(“breaks”); the break is related to increased tolerance to thermal injury that is 
developed during heating [26, 30]. There is insufficient data for human tissue to 
accurately define the breakpoint; most data show that it varies from 43.5 to 47°C 
[26, 30].   However, Lepock et al. [32] concluded that 43°C in cell culture likely 
represents the upper limit at which thermal tolerance can be induced in human 
cells.   
 
Because of the presence of a breakpoint, the calculation of CEM°43 has to occur 
in two steps using Eq. (3.1) separately above and below the breakpoint.   
 
𝑪𝑬𝑴𝟒𝟑°𝑪  𝒕[𝑹𝑪𝑬𝑴]
(𝟒𝟑 𝑻) (3.1) 
 
The symbol t is the time of thermal exposure.  The time-scaling ratio RCEM is the 
number of minutes needed to compensate for a 1°C change in the applied 
therapeutic temperature, either above or below the breakpoint, and T is 
temperature in degrees Celsius.  The breakpoint of 43.5°C is chosen here, with 
an RCEM below the breakpoint of 0.233 and above the breakpoint of 0.428. 
 
Eq. (3.1) can also be used in a differential and/or a discretized form if the thermal 
history is dynamic and known. 
 
𝑪𝑬𝑴𝟒𝟑°𝑪  ∫ [𝑹𝑪𝑬𝑴]






  (3.2) 
 
However, the process of integration/summation has to account for temperatures 
that occur both above and below the breakpoint.   
 
DAMAGE INDEX/INJURY INTEGRAL METHOD 
 
The second metric used to quantify thermal exposure and cell injury is the 
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damage index Ω.  This metric has been widely adopted by tissue ablation 
practitioners.  Thermal ablation is generally accomplished at higher temperatures 
than is hyperthermia.  Collagen is in high abundance and is, therefore, assumed 
to be one of the main proteins that are involved with thermal damage at these 
higher temperatures.  The typical thermal damage process is protein 
denaturation that follows a first-order chemical reaction.  The reaction state 
equation, combined with the temperature-dependent reaction rate, gives 
 
𝑫𝒂𝒎𝒂𝒈𝒆 𝑰𝒏𝒕𝒆𝒈𝒓𝒂𝒍   𝛀(𝒙 𝒕)  𝒍𝒏 (
𝑪(𝟎)
𝑪(𝒕)









C(0) – number of undamaged cells at the start of the treatment 
C(t) – number of undamaged cells at the end of the treatment 
A and ΔE – values determined experimentally and found in the literature 
R – universal gas constant, which is 8.314 kJ/kmole-°K 
t – time (seconds) 
T – temperature in absolute units (°K) 
It can be seen from the foregoing equation that the conditions that bring about 
cell necrosis involve both the temperature level and the length of time over which 
the temperature is applied, referred to as dose.  The amount of time required to 
reach necrosis varies inversely to the temperature that is used.  Higher treatment 
temperatures will achieve necrosis faster than lower treatment temperatures. 
 
A numerical value of this integral of Ω = 0.53 is regarded as the onset of 
irreparable tissue damage and numerical values that are equal to or greater than 
one are widely accepted as characteristic of complete necrosis [33].  While each 
treatment instance has its own requirements, typical desired depths of necrosis 
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are 3-5 mm as it is reported that endometrium regeneration will not occur at 
depths greater than 2 mm [18]. 
 
Relationship Between the Two Methods 
 
The CEM°43 and the  amage Index both originate from Arrhenius’ experimental 
observations in the 1880s [34, 35].  The results and their interrelationship are 
very well described by [36, 37-39]. 
 
Eyring’s introduction of the activation energy concept in the 1930s [37-41], that 
the reactants must surmount an activation energy barrier in order to form 
product, explained Arrhenius’ experimental observations and resulted directly in 
the theory of absolute reaction rates. 
 
When the time-scaling ratio RCEM is derived from the constant-rate region of cell 
survival curves where the slope is D0(T) and where the surviving fraction is 







PHYSICAL MODEL FOR THE PRESENT RESEARCH 
The tissue ablation model developed here is based on a sequence of thermal 
and fluid flow processes that globally obey Newton's Second Law for fluid flow, 
the First Law of Thermodynamics for phase change, the Fourier Law of Heat 
Conduction, and the Pennes Bioheat Model.  The delivered vapor is at an 
intrauterine gauge pressure of 42mm Hg and at a corresponding saturation 
temperature that is 101.51°C.  The uterine surface temperature is below that of 




The model developed for the aforementioned processes has built-in intelligence 
in that the rate of utilized steam flow is auto-regulated by the rate of 
condensation and the rate at which heat penetrates the uterine tissue.  This auto-
regulation is the result of the tight interconnection of all of the involved physical 
processes.  If the rate of delivered steam flow exceeds the auto-regulated value, 
it will leave the uterine cavity through the provided outlet.  Because the rate of 
utilized steam flow is auto-regulated, the pattern of vapor motion is not explicitly 
considered within the model. 
The change of phase from vapor to liquid deposits a condensate film on the 
uterine surface.  For each kilogram of steam that is condensed, approximately 
2250 kJ of thermal energy is liberated. The thickness of the film grows with the 
passage of time.  Since the liberation of latent heat occurs at the vapor-liquid 
interface of the growing film, the heat must first pass through the liquid film 
before it reaches the uterine surface.  The thickening of the condensate film 
creates a concomitant increase of the resistance to trans-film heat flow.  Another 
impact of the increased thermal resistance is an increase of the temperature drop 
across the film.  As a consequence, the uterine surface temperature is below 
both the condensation temperature of the vapor and the boiling-point 




Figure 3.9 – Illustration of condensate film on uterine lining 
The thermal energy deposited on the uterine wall by condensation penetrates the 
uterine tissue by two transport mechanisms.  One of these is heat conduction, 
which is a molecular-level process that is indigenous to all media.  Human tissue 
is not a good conductor of heat.  The thermal conductivity of uterine tissue varies 
with several parameters including, among others, the water content in the tissue, 
[42].  For the current work, it is appropriate to use a value of approximately 0.5 
W/m-°C.   It is of the same order as biomedical fluids, as can be seen in Table 
3.1. 
Table 3.1 – Thermal conductivity values of common relevant substances 
Material Thermal Conductivity (W/m-°C) 
Uterine tissue 0.5 [43] 
Blood 0.49 [44] 












A second heat transport mechanism is blood perfusion, which is a seepage-like 
process.  Heat is carried by the perfusing blood, also called the “heat sink” effect.  
Living tissue experiences blood perfusion, but necrotic tissue does not.  In 
partially necrosed tissue, the rate of perfusion is significantly diminished.  These 
in-vivo processes are brought together in the bioheat equation. 
Based on a careful evaluation of the biomedical literature, uterine cavity lengths 
of 26, 46, and 86 mm were selected for the numerical simulations.  With the 
assumption of an average cervical length of 34 mm, these cavity lengths 





The physical processes that were described in the foregoing are governed by 
universally accepted conservation laws.  The fluid flow and thermal energy 
transport in the vapor that floods the uterine cavity and in the condensed liquid 
must respectively obey Newton’s Second Law, the law of mass conservation, the 
First Law of Thermodynamics, and the phase equilibrium law for water 
substance.  For laminar flow, they are 
Conservation of mass 
   
   
   
(3.5) 
 
Newton’s Second Law for a fluid experiencing laminar flow 
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First Law of Thermodynamics 
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In these equations: 
ui – velocity components of the flowing fluid (m/s) 
T – temperature (°C) 
p – pressure (kg/m2) 
ρ – fluid density (kg/m3) 
μ – dynamic viscosity (kg/m-s) 
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k – thermal conductivity (W/m-°C) 
cp – specific heat (J/kg-°C) 
xi – coordinates 
t – time (s) 
In addition to the foregoing equations, the phase change must occur in 
accordance with the liquid-vapor saturation curve for water substance.  That 
curve is often referred to as the Clausius-Clapeyron relation and is presented in 
Figure 3.10.  The figure shows the phases in question and the pressure and 
temperature coordinates which define those phases.  Also shown is a point which 
indicates the state at which the vapor enters the uterine cavity.  It can be seen 
that the vapor is slightly superheated. 
 
Figure 3.10 – Liquid-vapor saturation curve for water substance and a point 
corresponding to the inlet state of the vapor. 
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The water substance that enters the uterine cavity is a pure vapor whose 
temperature is 101.9°C and whose absolute pressure is 802 mmHg.  The 
saturation temperature corresponding to this pressure is 101.5°C.  Therefore, the 
vapor is slightly superheated.  When the vapor contacts the uterine wall, whose 
initial temperature is on the order of 37°C, its temperature drops while the near-
wall pressure drops slightly.  In terms of the saturation diagram, the initial near-
wall state is vapor.  The slight near-wall pressure drop serves as a defacto pump 
in that it creates a pressure difference between the bulk vapor and the near wall.  
The condensate flow is governed by Eq. (3.5) and (3.6) with appropriate fluid 
properties.  Similarly, the transfer of thermal energy in the liquid film obeys Eq. 
(3.7), but with the properties of the liquid.  
The boundary conditions for the fluid flow represented by Eqs. (3.5) and (3.6) are 
the well-established no-slip and impermeability that prevail at all solid surfaces.  
On the other hand, the thermal boundary condition for the energy equation Eq. 
(3.7) is expressed by continuity of temperature and heat flux at all interfaces. 
The transfer of thermal energy within the tissue was modeled by the Pennes 
Bioheat equation [46], which is a specific form of the First Law of 
Thermodynamics. This equation is the most widely used for bioheat processes in 
tissue.  Many more detailed bioheat equations have been proposed, but they 
universally suffer from the fact that they contain unknown constants that are 
additional to the few that appear in the Pennes model.  Because of this situation, 
the use of bioheat models other than that of Pennes is a rare occurrence.   
The form of the Pennes Bioheat equation that was utilized for the tissue 
comprising the uterine wall is: 
(   )      




   
(       
        
   
)   (   )     (               ) 
             (3.8) 
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In this equation, ω represents the volumetric flow rate of perfusing blood per unit 
volume of tissue, and Qmetabolic is the volumetric rate of metabolic heat 
generation.  The following values were used in the numerical simulation: 
 ρtissue = 980 kg/m
3 
 cp of tissue = 3800 J/kg-K 
 ktissue is a function of temperature = -0.00679368*T + 2.627  W/m-K 
 (ρcp)blood = 4.1 x 106 J/m
3-K 
 ω = 0.0005 s-1 







A finite-volume approach was used to implement the numerical simulation 
utilizing the commercially available software package ANSYS CFX, version 14.0.  
The geometry was modeled as being axisymmetric to help conserve 
computational resources while maximizing nodal density.  The several 
interlocking physical processes are all unsteady and vary throughout the volume 
of the uterine cavity and its enveloping tissue wall.  To capture the time-
dependent response, the solution was run as a transient covering the 140-
second steam treatment.  The time span was divided into 2800 time steps, giving 
a time step of 0.05 seconds. 
In the case of the smallest uterine cavity (26 mm), the numbers of nodes needed 
were 1,708,700 and 250,900 for the tissue and fluid regions respectfully 
(1,959,600 nodes in total).  The placement of the nodes was performed in a 
manner that resulted in significantly higher nodal densities closest to the uterine 
wall.  This increased nodal density is required to achieve accurate results for the 






APPLICATION OF A NECROSIS CRITERION  
The numerical simulations provide spatial variations of the temperatures 
throughout the entire solution domain for all times between the initiation of the 
therapy and 140 seconds thereafter. At any selected spatial location, a complete 
time history is available. Consequently, the information needed to assess the 
attainment or non-attainment of necrosis at that location is at hand.  
As was discussed in detail earlier, the most widely accepted means of assessing 
the state of tissue ablation subjected to elevated temperatures is Eq. (3.3). That 
criterion is widely termed the Henriques-Moritz integral criterion.  The integral 
that appears in Eq. (3.3) takes account of both the instantaneous magnitude of 
the temperature and the times over which the varying temperature prevail. When 
Eq. (3.3) is specialized to the time integral that is relevant to the present therapy, 
there results:  
   ∫        
 =       
 = 
   (3.9) 
In this equation, the symbols A, ΔE, R, and T respectively denote the pre-
exponential constant, the activation energy, the universal gas constant, and the 
instantaneous temperature. The symbol t denotes time. The values of A and ΔE 
are specific to the type of tissue involved which, for uterine tissue, are 3.10 x 1098 
s-1 and 6.27 x 108 J/kmole respectively [47]; the value of R is 8.314 kJ/kmole-K. 
As noted earlier, the threshold of irreparable tissue damage corresponds to Ω = 
0.53 and that total necrosis is achieved for Ω = 1.  
The methodology employed for the evaluation of Eq. (3.9) was initiated by the 
selection of a specific location on the surface of the uterine cavity. Along a line 
perpendicular to the surface at that location and in the direction beneath the 
surface, a set of points were selected, and the Ω integral was evaluated at each 
of these points. As expected, very large values of Ω were encountered near the 
surface of the uterine cavity. At points situated at increasing depths beneath the 
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surface, the values of Ω decreased monotonically. When the values of Ω = 0.53 
and 1.0 were encountered, note was made of the corresponding locations and 
this information was stored for later presentation.  
SIMULATION RESULTS 
PREDICTED NECROSIS DEPTHS  
Results for the depth of necrosis have been extracted from the numerical 
simulations at four critical locations along the circumference of the uterine cavity.  
Those locations and their designations are illustrated in Figure 3.11.  The results 
for the three selected geometric lengths of uterine cavities are displayed in 
 
Figure 3.11 – Illustration of the four critical locations and their naming convention 
Figures 3.12-3.14, respectively for lengths of 26, 46, and 86 mm. With the 
assumption of an average cervical length of 34 mm, these cavity lengths 







Figure 3.12 displays necrosis depths for the cavity length of 26 mm.  Inspection 
of the figure indicates depths ranging from 3.2 to 4.1 mm. It may be noted that 
the necrosis depths encountered along the long wall of the cavity are slightly 
 
 
Figure 3.12 - Simulation-based necrosis depths (Ω = 1) for a uterine cavity of 26 
mm in length (corresponding to total uterine length of 60 mm). The numerical 
values indicated in the diagram correspond to necrosis depths achieved with a 
140-second treatment. 
greater than those at the end wall (i.e., the fundus).  These results will be 
compared to experimental data shortly. 
Necrosis depth results for cavity lengths of 46 and 86 mm are presented in Figs. 
3.13 and 3.14, respectively. The numerical values of the depths are in the same 
range for all three of the investigated lengths, and, generally, the same trends 




Figure 3.13 - Simulation-based necrosis depths (Ω = 1) for a uterine cavity of 46 
mm (corresponds to 80 mm total uterine length) in length. The numerical values 
indicated in the diagram correspond to necrosis depths achieved with a 140-
second treatment. 
  
Figure 3.14 - Simulation-based necrosis depths (Ω = 1) for a uterine cavity of 86 
mm in length (corresponding to 120 mm total uterine length). The numerical 




The results from the numerical simulations will now be compared with those from 
experiments [48].  These experiments were performed on patients who had 
agreed that hysterectomy was the more appropriate treatment for their situation.  
Each of the treated uteri was carefully evaluated immediately upon the 
completion of the hysterectomy.  Table 3.2 has been created to bring together 
the results from the simulations and those from experiment.  Note that the 
experimental data were not classified according to the length of the uterine 
cavities.   
The table is constructed in two parts.  The upper part displays results from the 
numerical simulations, separately for the three selected uterine lengths.  For 
each of the lengths, necrosis depths are indicated at the four critical locations 
identified earlier.  To facilitate comparisons with the experimental data, for which 
only average values over the patient population are available, the numerical 
values from the simulations were also averaged at each of the critical locations.  
The lower portion of the table exhibits the experimental data, separately 
categorized as the average maximum values and the average minimum values of 
the measured necrosis depths.  
Not unexpectedly, the simulation-based predictions are lower than the average of 
the maximum values from the experiments.  These deviations are moderate for 
the Fundus, Cornu and Corpus locations.  On the other hand, the deviation in 
evidence at the LUS location is considerably greater than that at the other three 
locations.  This outcome cannot be presently definitively explained.  However, a 
comparison of the average maximum and average minimum values of the 
experimental data reveals that the greatest differences occur at the LUS location.  
This finding suggests that large variations among individual measurements 
existed at that location, thereby diminishing concerns about the large deviation 




Table 3.2 – Comparison of necrosis (Ω = 1) depth results from numerical 
simulation to experimental (pathology) results [48] 
 
Case Description 
Necrosis Depth (mm) 
(from Figs. 3.12-3.14) 















26 mm 3.41 3.23 4.05 3.72 
46 mm 3.21 3.72 3.76 3.26 
86 mm 3.30 3.12 3.54 3.40 
Average for all cavity 
lengths 3.31 3.36 3.78 3.46 
Pathology Results 
Average Ablation 
3.21 2.82 3.77 3.82 
 
The numerical simulations also provided tissue depths at which the tissue 
damage criteria Ω = 0.53 were encountered.  A comparison of the tissue depth 
results for these two different Ω values from the numerical simulations is 





Table 3.3 – Comparison of numerical predictions of tissue depth corresponding 






Necrosis Depth at Specified 
Circumferential Location (mm) 
Fundus Cornu Corpus LUS 
26 mm 
0.53 3.53 3.48 4.25 3.82 
1.0 3.41 3.23 4.05 3.72 
46 mm 
0.53 3.33 3.95 3.97 3.37 
1.0 3.21 3.72 3.76 3.26 
86 mm 
0.53 3.42 3.34 3.77 3.61 
1.0 3.30 3.12 3.54 3.40 
Average 
0.53 3.43 3.59 4.00 3.60 
1.0 3.31 3.36 3.78 3.46 
Pathology Results 
Average Ablation 
3.21 2.82 3.77 3.82 
 
Inspection of the table shows that for all cases, the Ω = 0.53 criterion was 
encountered at a slightly greater depth than was the Ω = 1.0 metric.  The 
differences between the respective depths are generally small, with the largest 
differences being on the order of 0.2 mm. 
Inasmuch as the temperature wave that penetrates the  uterine lining does not 
necessarily cease its penetration at the moment when the therapeutic treatment 
ceases, the simulations were extended from the end of the therapy (140 
seconds) to 400 seconds, adding an additional 260 seconds.  The conditions of 
irreparable tissue damage, or complete necrosis, are caused not only by the 
elevated temperatures, but also the duration of time that the tissue experiences 
the elevated temperature.  Necrosis might occur after being at an elevated 
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temperature T1 for a duration of X seconds, but it is possible to achieve necrosis 
of the same tissue after being at a lower temperature T2 where T2 < T1 for a 
longer period of time, Y seconds such that Y > X.   
Table 3.4 – Comparison of necrosis depth results from numerical simulation, 





Necrosis Depth at Specified Location (mm) 
Fundus Cornu Corpus LUS 
26 mm 
140 3.53 3.48 4.25 3.82 
400 4.07 3.83 4.68 5.57 
46 mm 
140 3.33 3.95 3.97 3.37 
400 3.83 4.35 4.55 3.85 
86 mm 
140 3.42 3.34 3.77 3.61 
400 3.93 3.74 4.31 4.09 
Averages 
140 3.43 3.59 4.00 3.60 
400 3.94 3.97 4.51 4.50 
Pathology Results 
Average Ablation 
3.21 2.82 3.77 3.82 
 
Table 3.4 shows that the numerically predicted depths of necrosis corresponding 
to the end of the extended treatment are much closer to the average maximum 
ablation depths from the experiments than are those encountered at the 
conclusion of the period of actively applied therapy.  This outcome suggests that 
during the time period between the end of the therapy proper and the extraction 
of the uterus, thermal penetration continued. 
Information similar to that conveyed by Table 3.4 but relevant to the Ω = 1 




Table 3.5 – Comparison of necrosis depth results from numerical simulation, 





Necrosis Depth at Specified Location (mm) 
Fundus Cornu Corpus LUS 
26 mm 
140 3.41 3.23 4.05 3.72 
400 3.83 3.59 4.45 5.34 
46 mm 
140 3.21 3.72 3.76 3.26 
400 3.65 4.04 4.33 3.68 
86 mm 
140 3.30 3.12 3.54 3.40 
400 3.75 3.52 4.10 3.82 
Averages 
140 3.31 3.36 3.78 3.46 
400 3.74 3.72 4.29 4.28 
Pathology Results 
Average Ablation 
3.21 2.82 3.77 3.82 
 
Once again, the average necrosis depths for all three cavity lengths are 
compared in the table with the average maximum values from the experiments.  
In general, there is very good agreement between the simulation-based results 
and the experimental values.  The only deviation from this conclusion is at the 
LUS location.  The justification for that deviation has already been set forth 
earlier. 
To complete the presentation of the necrosis depth information, Figures 3.15-
3.17 were prepared.  These figures are the counterparts of Figures 3.12-3.14, 
except that the earlier figures corresponded to Ω = 1.0 and the current figures are 
for Ω = 0.53.  These figures are for the termination of the application of the 
treatment, 140 seconds.  The trends in evidence in Figures 3.15-3.17 mirror 




Figure 3.15 - Simulation-based irreparable tissue damage (Ω = 0.53) depths for 
a uterine cavity of 26 mm (corresponds to 60 mm uterine length) in length. The 
numerical values indicated in the diagram correspond to tissue damage depths 
achieved with a 140 second treatment. 
 
Figure 3.16 - Simulation-based irreparable tissue damage (Ω = 0.53) depths for 
a uterine cavity of 46 mm (corresponds to 80 mm uterine length) in length. The 
numerical values indicated in the diagram correspond to tissue damage depths 




Figure 3.17 - Simulation-based irreparable tissue damage (Ω = 0.53) depths for 
a uterine cavity of 86 mm (corresponds to 120 mm uterine length) in length. The 
numerical values indicated in the diagram correspond to tissue damage depths 
achieved with a 140 second treatment. 
 
TEMPERATURE DISTRIBUTIONS  
Spatial temperature distributions will be presented from two points of view. The 
first is a display, by means of color contour diagrams, of the distribution of 
temperature throughout the uterine tissue at the termination of the treatment (140 
seconds of vapor delivery).  This information is conveyed in Figures 3.18-3.20 for 
the cavity lengths of 26, 46, and 86 mm (corresponding to total uterine lengths of 
60 mm, 80 mm and 120 mm, respectively). 
The colors that characterize the spatial temperature distributions are keyed to a 
legend appearing at the left of the respective figures.  To facilitate easy appraisal 




Figure 3.18 - Simulation-based distribution of temperature throughout the uterine 
tissue at the termination of the 140-second treatment for a cavity of 26 mm in 
length (total uterine length of 60 mm). 
 
 
Figure 3.19 - Simulation-based distribution of temperature throughout the uterine 
tissue at the termination of the 140-second treatment for a cavity of 46 mm in 





Figure 3.20 - Simulation-based distribution of temperature throughout the uterine 
tissue at the termination of the 140-second treatment for a cavity of 86 mm in 
length (total uterine length of 120 mm). 
Inspection of the figures reveals a general similarity in the temperature results for 
the three cavity lengths, with small differences in detail.  The shorter cavities 
experience somewhat higher temperatures than their longer relative as 
witnessed by the appearance of the orange and yellow colors at the upper end of 
the cavity.  Furthermore, it is clear that the temperature distribution patterns are 
affected by the steam distribution along the surface of the cavity wall.  Clearly, 
the intermediate-length cavity experiences a highly uniform steam delivery.  In 
contrast, the steam delivery is evidently non-uniform for the longest of the 
cavities. 
The second mode of spatial temperature-distribution presentation is in terms of a 
graph, Figure 3.21.  In the figure, the temperature is plotted on the vertical axis 
while the distance from the cavity surface is represented on the horizontal axis.  
There are several curves which are parameterized by times ranging from 15 to 
140 seconds.  At any fixed time, the temperature is seen to decrease 
58 
 
monotonically with increasing distance from the cavity surface.  Further 
inspection reveals that the most rapid decrease of the temperature with depth 
occurs at the shorter times.  It can be seen from the figure that the temperatures 
never exceed the boiling temperature that corresponds to the pressure within the 
cavity.  For increasing times following the initiation of the treatment, the tissue 
temperatures display an increasing trend.      
 
Figure 3.21 - Typical temperature distributions as a function of tissue depth 
beneath the cavity surface for various times during the therapy application. 
 
Heat transfers through the uterine tissue by means of conduction, with a rate 
defined by the thermal conductivity of the tissue, and heat carried by blood 
perfusion, as illustrated in Eq. (3-8).  The rate of heat transfer due to blood 






























ultimately define the rate at which the temperature wave travels through the 
tissue over time.  To illustrate this phenomenon, three points were selected in the 
uterine tissue at which the temperature as a function of time is plotted in Figure 
3.22.  The three points are all located half-way up the side of the uterine wall, 
and 1, 2 and 3mm deep into the tissue, orthogonal from the tissue-fluid interface.  
The Figure shows that the temperature rise starts at a later time, and rises at a 
slower rate as the distance from the uterine wall is increased. 
Figure 3.22 – Temperature of the uterine tissue at various distances from the 



























1mm from uterine wall
2mm from uterine wall




A numerical simulation model, implemented fully independently of clinical data, 
has demonstrated the efficacy of using water vapor as a means for treating 
menorrhagia.  The model is based on first principles encompassing Newton’s 
Second Law, the First Law of Thermodynamics for energy transport and phase 
change, the Clausius-Clapeyron relationship for phase equilibrium, the 
conservation of mass, Fourier’s Law of heat conduction, and the Pennes Bioheat 
Equation. 
The thermal energy needed for creating elevated temperatures in the tissue 
within the uterine cavity was provided by the latent heat of condensation of the 
steam.  The rate of steam utilization is auto-controlled by the intimate interactions 
of the participating physical processes.  Any delivered steam in excess of that 
needed for the therapy is vented outside the uterine cavity through the vapor 
probe. 
The numerical simulations provided highly detailed information for the temporal 
and spatial distributions of temperature in the tissue that bounds the uterine 
cavity.  This information was post-processed by means of the well-established 
Henriques-Moritz thermal damage integral.  The values of this integral constitute 
a metric for establishing both the onset of irreparable tissue damage and the 
attainment of complete necrosis. 
The numerical simulations were carried out for two time durations following the 
initiation of the therapy.  One of these durations, 140 seconds, corresponds to 
the period during which the steam is being actively supplied.  To take account of 
temperature spreading throughout the tissue subsequent to the cessation of the 
steam supply, the simulations were extended to 400 seconds.  The necrosis 
depths corresponding to the extended time duration were found to be slightly 
greater than those for the applied therapy period. 
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The necrosis depths corresponding to these operating conditions were compared 
to available experimental information.  The experimental results were obtained 
from post-inspection of extracted uteri which had been previously subjected to 
the vapor-based necrosis treatment.  The extraction of the uteri was based on 
physicians’ opinions that the dysfunctional condition had gone beyond the point 
where the therapeutic process could make a difference.  The patients had 
volunteered to serve as subjects for the evaluation of the therapeutic process 
knowing that their uteri would ultimately be removed.  The experimental results 
were grand averages encompassing uteri of various dimensions and at various 
stages of dysfunction. 
The numerically predicted necrosis depths were compared to the average values 
obtained in the experiments.  In general, the agreement between the depths of 
necrosis obtained from the simulations and those from the experiments were 
highly satisfactory.  Only at the LUS location were there sizable deviations.  
However, there is compelling evidence of substantial scatter of the experimental 
data at that location, so that the deviations between the simulation and 




CHAPTER 4 – DESIGN METHODOLOGY FOR DELIVERING 
A THERAPEUTIC DRUG IN PARTICULATE FORM 
INTRODUCTION 
The investigation to be described in this chapter is a continuation of the theme of 
fluid-mechanic-based therapies.  The focus of this chapter is to develop a 
methodology for delivering therapeutic drugs that enter the human body either 
through the mouth or the nostrils.  For the applications in question, the drug may 
be delivered either in particle or droplet form.  The issue at hand is to be able to 
predict the trajectory of these discrete entities as they pass from their point of 
admission to their targets within the respiratory system.  The prediction of these 
trajectories is highly complex, owing especially of the complicated geometries of 
the flow passages in question. 
Since the issue at hand is experiencing increased current interest in the 
biomedical community and the pace of related research is accelerating, the 
literature review was focused on the very recent past.  It appears that the present 
state of capability in the numerical modeling of the complex flow passages has 
been confined to the upper reaches of the respiratory system.  To illustrate the 
nature of the current level of accomplishment with regard to the flow-
configuration modeling of the upper respiratory system, Figure 4.1 is presented.  
Models of this type were employed in numerous numerical simulations such as 
those reported in [49-51].  As can be seen from the figure, the geometry is not 
only highly simplistic but does not extend into the highly complex lung region.  




Figure 4.1 – Illustration of the state of the art of the modeling of the upper 
respiratory geometry 
in October of 2013 [52].  That paper is a state-of-the-art review of modeling of 
drug delivery to deeper regions of the respiratory system.  The review confirms 
the need for higher fidelity modeling than has appeared in the published 
literature.  That outcome reinforces the motivation and the goals of the present 
investigation. 
The objective of this work is to create a methodology suitable for application to 
problems of the type mentioned in the foregoing.  It is well understood that the 
geometry of the respiratory system is not only complex, but also differs among 
individuals based on age, gender, and physical condition, among others.  In this 
light, the task undertaken here is not specific to any of these categories.  Rather, 
the development is carried out for a geometry of sufficient complexity to ensure 
the applicability of the developed methodology to a variety of complex 
geometries. 
The fluid flow problem, without particulates, is very complex in its own right.  The 
approach used here is to first solve for the fluid flow and subsequently take the 
particle motion into account.  The investigation is performed for inhomogeneous 
particle-size distributions and is aimed at determining the sites at which the 




PARTICLE TRANSPORT IN THE HUMAN RESPIRATORY 
TRACT 
The path of particle motion in the human respiratory tract is determined by the 
presence of multiple physical phenomena.  In any specific case, one such 
physical process may dominate over the others and determine the resultant 
trajectory and deposition location.  In general practice, particle motions can be 
driven by gravitational, electrical, inertial, or diffusional forces.  However, 
pharmaceutical particles are generally not charged and, therefore, there are no 
electrical forces to consider in the application of current study, and attention will 
be focused on the mechanical forces encountered.  Furthermore, it has been well 
documented that an individual’s breathing pattern has a profound effect on the 
delivery of a nebulized drug [53]. 
Particle transport by diffusion has the greatest effect when particle sizes are 
extremely small, typically less than 0.1 µm in diameter.  Particles of this size 
interact with the surrounding carrier gas in a manner that is similar to collisions 
between particles.  Each collision of a particle with a gas molecule changes the 
particle’s direction of motion.  This ultimately results in a random path that is 
independent of particle density.  The observed randomness increases with time 
or decreasing particle size.  As a result, it is reasonable to expect that diffusional 
deposition to govern in small airways such as those in the lung periphery [54]. 
At particle sizes larger than 0.1 µm, diffusion plays a smaller role in the transport 
path and other forces such as gravity and inertia play stronger roles.  
Gravitational forces play an increasing role with the increase of diameter, density, 
or time.  Similar to the diffusion mechanisms, the time-dependence of 
gravitational transport suggests that it will be most prominent in areas of 
maximum residence time such as in small airways in the lung periphery. 
Particle transport by means of inertia can be referred to as impaction.  Particles 
of increasing size and density will have inertial displacement resulting from the 
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velocity of the air in the passageways.  As the air velocity, particle size, or 
particle density increases, this transport modality becomes a more dominant 
factor in particle deposition patterns.  In summary, the transport path of the 
smallest particles, termed ultrafine, is dominated by the diffusion mechanism.  As 
particles get larger in size, gravitational forces contribute more to the particulate 
path.  Of these larger particles of a given size, as the density increases, the 
inertial transport mechanism has a larger effect on the ultimate deposition 
patterns.  Coincidentally, all particles with density, ρ, and diameter, d, which have 
an equivalent product of (ρd2) are said to have the same aerodynamic behavior.  
In this instance, those particles will have the same gravitational displacement.  
Since both gravitational and inertial transport mechanisms are dependent on 
(ρd2), they will have the same inertial transport as well.  This approximation is not 
always appropriate.  To be complete, the particle transport is influenced by slip 
force correction factors.  The value of these correction factors depends on the 
relative difference of the particle’s aerodynamic diameter and the mean free path 
of the surrounding carrier gas.  In this application, it is determined that particles 
larger than 1 μm can neglect these correction factors with reasonable accuracy 
[54].  As such, these factors have not been included in the study at hand. 
PARTICLE INERTIAL IMPACTION 
Devices called particle impactors have been employed for many years to 
systematically sort particles which are entrained in an air stream based on their 
aerodynamic size.  Such devices have been in favor due to their simple mode of 
operation and relative simplicity of design and manufacture.  In the most simple 
view, an impactor directs a particle-laden airstream through a nozzle which 
discharges onto a target surface.  The common principle under which all particle 
impactors operate is that high-inertia particles in an air stream will impact on the 
target surface, while lower-inertia particles will continue to follow the fluid 
streamlines [55].  A proper design of the impactor, including the diameter and 
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shape of the nozzle, the distance from the target surface, and the velocity of the 
airflow through the system will result in an accurate means of segregating 
particles based on their aerodynamic size.  If the particles are of the same 
material, then the impactor will effectively sort the particles based on their 
physical size. 
The aforementioned sorting process can be expanded to create more complex 
devices such as cascade or parallel impactors.  In the case of a cascade 
impactor, the air stream is directed by means of a nozzle at a first target plate 
which is designed to collect particles that are larger than a specific size.  Any 
particles that are smaller than this size will not impact the plate and will continue 
to follow the fluid stream.  After passing the first collection plate, the flow and its 
cargo of particles will congregate in a plenum before being directed through a 
second nozzle, aimed at a second target plate.  The second nozzle and its 
distance from the target plate will be different from that of the first.  The design 
parameters of the second impactor will be such that it will collect particles that 
are smaller than those already collected at the first plate, but larger than the 
others in the air stream.  This process can be repeated for many stages, resulting 
in an effective mechanism to separate the particles in an air stream into many 
different size ranges. 
Figure 4.2 shows an example of a single-stage and a cascade-type particle 
impactor.  The single-stage impactor is shown on the left side of the figure.  In 
this configuration, the particles follow the streamlines through the nozzle and are 
directed towards the collection plate.  Only particles of sufficient size, namely 
those that are larger than the design cutoff size, will impact and be collected on 
the plate.  Any other particles that are smaller than the cutoff size will not have 
sufficient inertia to strike the plate, and will therefore continue out of the device 
with the exhausted air.   
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The illustration on the right side of the figure depicts a three-stage cascade 
impactor.  In this configuration, the particle-laden airflow enters the device with 
particles of various sizes.  The design parameters of the device are such that as 
the flow passes through the first nozzle and impacts on the plate (labeled Stage 
3 in the figure), any particles larger than 10 µm will be collected.  After passing 
through this stage, the air flow and remaining particles will continue out of this 
stage and enter the next stage (labeled Stage 2 in the figure).  The design of the 
nozzle and the distance to the plate of Stage 2 are such that particles that are 
larger than 2.5 µm but less than 10 µm will impact and be collected.  In a similar 
fashion, the air flow and remaining particles will next flow through the third 
nozzle, directed at the final collection plate (labeled Stage 1 in the figure).  At this 
stage, particles that are larger than 1 µm but smaller than 2.5 µm will be 
collected.  Finally, the airflow will exit the device, along with any particles that are 
smaller than 1 µm.  In various commercially available devices, the flow will pass 
through a filter medium designed to collect the last remaining particles that are 
still in the flow stream. 
 
Figure 4.2 – Illustration of a single stage and cascade impactors. 
Particle impactors are often classified by the size of particle they are designed to 
separate, commonly referred to as the cutoff size.  The size is often designated 
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as d50 to indicate a 50% collection efficiency at the size noted as d.  Figure 4.3 
demonstrates an ideal and an actual cut-off curve for a typical impactor.  A 
perfect impactor would behave according to the ideal curve, shown as a vertical 
line in the figure, whereby any particles larger than a given size would be 
collected and all particles smaller than the designated size would pass through.  
Real-world applications have various inefficiencies which prevent this ideal curve 
from occurring and instead give a performance curve like the actual one shown.  
The characteristic parameter of a given impactor is the size of the particles 
collected.  The efficiency curve is based on the square root of the Stokes number 
(Stk), which is a dimensionless parameter comparing the particle’s characteristic 
response time to the response time of the fluid [56].  The Stokes number is 
defined as: 
     
   





ρ – density of particle 
d – diameter of the particle 
   – velocity of the fluid 
µ – viscosity of the fluid 
L – representative length of the target surface 
If the Stokes number is much less than one, the particle is tightly coupled to the 
fluid flow and has a low probability of being collected.  If the Stokes number is 
large, then the particle is much less dependent upon the fluid flow, and its 





Figure 4.3 – Sample efficiency curve of particle impactor 
PHYSICAL MODEL 
Figure 4.4 depicts the flow model used here for the detailed study of the 
particulate flow.  The objects that are encountered by the fluid along its flow path 
are shown in different colors to help distinguish one from the other.  The system 
is comprised of potential collection zones connected together by bridging 
passageways.  This configuration is believed to contain sufficient complexity to 
be suitable for the development of a methodology for treating drug delivery 


















Figure 4.4 – Illustration of the flow pattern of study.  Arrows are included to 
indicate the general direction of flow through the zones. 
The model is arranged in such a manner that the lower zones, zones of even 
numbers 2 – 10, serve as potential particle collectors.  The upper zones, those of 
odd numbers 3 – 9, serve as passageways that connect one collection zone to 
the next.  The incoming air-particle mixture enters through the circular opening 
marked as number 1 in the figure.  The flow continues through the snorkel-like 
tube assembly before discharging into the first potential collection zone marked 
as number 2 in the figure.  The inlet snorkel may be viewed as an approximation 
of the mouth and throat in the human body. 
Each successive collection zone is different from the previous one.  As illustrated 
in Figure 4.5, the first potential collection zone, zone number 2, is of the simplest 
form whereby the incoming air-particle mixture enters through a single round 
opening in the top center and impinges on the flat bottom of the zone.  Once 
inside the zone, the flow will recirculate until it exits through the round opening in 













Figure 4.5 – Top view of collection zone number 2.  All collection zones are of 
like size. 
marked number 3.  The air discharges from passageway number 3 and enters 
the second collection zone, labeled number 4, as seen in Figure 4.4.   
The dimensions of the objects may be assessed by referencing the scale in 
Figure 4.5.  As can be seen, the length of the first collection zone, labeled 2, is 
on the order of 10 cm.  The height of each zone is approximately 1.5 cm.  
Figures 4.6 and 4.7 respectively depict the second and third collection zones, 
labeled numbers 4 and 6, and show the increasing number of round openings 
through which the fluid flows into the zone.  The figures are shown to scale, 
making it easy to see that each of these openings is of smaller diameter than the 
opening through which the flowing medium entered into its predecessor 
collection zone.  As the flow continues through the system, it enters each 
successive collection zone through a larger number of smaller-diameter openings 
than those of the previous collection zone.  The final collection zone utilizes 152 
holes whose diameter is 0.5 mm each.  This pattern continues until the flow has 
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passed through all of the collection zones and finally exits through the round 
opening in the top of zone 10. 
 
 
Figure 4.6 – Top view of collection zone number 4. 
 
 
Figure 4.7 – Top view of collection zone number 6. 
For the numerical simulations, a steady turbulent flow model was adopted.  The 
inlet cross section, identified as station 1 in Figure 4.4, was designated as an 
opening.  In computer parlance, an opening is a very weak boundary condition 
which enables the fluid to find its own direction, either to enter or leave.  A further 
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the module 
through these six 
round openings 
Mixture flows out of 
module 4 through this 
round opening 
Mixture flows 




Mixture flows out of 




constraint of this boundary condition is that the direction of fluid flow across the 
opening is prescribed to be perpendicular to the opening.  In addition to the 
specification of the inlet boundary condition as an opening, it is also necessary to 
prescribe the pressure.  The specified pressure is zero, so that all other 
pressures are regarded as gauge pressures.  At the exit of the system, the mass 
flow rate was prescribed as 0.0005925 kg/second.  This configuration 
corresponds to operation in the suction mode. 
COMPUTATION METHODOLOGY 
A finite-volume approach was used to implement the numerical simulation 
utilizing the commercially available software package ANSYS CFX, version 14.0.  
The geometry was meshed with a total of 4.75 million nodes.  Such high 
numbers of nodes often prove to be very difficult to solve and obtain a reliable 
result.  The method used in this work was to first reduce the geometry to contain 
only one collection zone and obtain the corresponding velocity solution.  The 
geometry was then extended to include both the first and second zones.  The 
use of velocity values determined in the prior solution provided reasonable 
velocity values to start the new solution.  This methodology was continued, 
adding one module at a time until the final solution of five collection zones was 
reached.  This approach was an innovation necessary to actually obtain 
convergence. 
Due to the highly complex geometry, the numerical simulations were first 
conducted by solving for the fluid flow without any particles present in the 
simulation.  Once an accurate velocity solution was obtained for all five collection 
zones, it was held constant and used for the next simulation which included the 
particles.  The particles were included in the numerical simulation with a one-way 
interaction scheme.  In this method, the presence of the particles has no 
influence on the fluid flow itself.  This approach is reasonable considering the 
size and mass of the particles used are very small. 
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In addition to the large number of nodes, their deployment is a critical factor.  The 
placement of the nodes was performed in a manner that resulted in significantly 
higher nodal densities closest to the bottom of each collection zone as well as 
through the various ports that carried the fluid into the collection zones.  This 
increased nodal density is required to achieve accurate results for accurate fluid 
flow solutions and the particle deposition rates of interest. 
The bottom surface of each collection zone was defined as having a coefficient of 
restitution equal to zero in both the perpendicular and parallel directions for 
particle impingement.  This adoption was logic-based because the surface in 
question is coated with a sticky substance.  Due to the aforementioned 
specification of the restitution coefficients, if any particle comes in contact with 
the bottom surface, it will stick to that surface and not continue through the 
system.  All other surfaces of the collection zones and the surfaces of the 
connecting passageways utilized a coefficient of restitution equal to one and, 
therefore, allowed the particles to be reflected and continue through the system. 
Particles of various distinct sizes were introduced into the system at the inlet.  
The largest size of particle used was 13 µm in diameter.  The other particle sizes 
used were 8 µm, 5 µm, 3.1 µm, and 1.8 µm in diameter.  The material used for 
the particles was aluminum, giving single particle mass values ranging from 3.1 x 
10-12 to 8.3 x 10-15 kg.  The particles were introduced at a rate of 100 per second 
of each size with an inlet velocity of 0.634 m/sec, matching that of the incoming 





FORMULATION OF THE FLUID FLOW PROBLEM 
To enable an unprejudiced approach to the fluid flow problem, a constitutive 
model was adopted which auto-determines the flow regime, encompassing 
laminar, intermittent, and fully turbulent.  This multi-regime model is based on 
three interlocking sets of equations.  The first set consists of the Reynolds-
Averaged Navier-Stokes equations (RANS) and the equation of mass 
conservation.  The RANS equations represent a first-stage introduction of 
turbulence into the traditional Navier-Stokes equations by means of the turbulent 
viscosity μturb. 
 
The second set of equations is that which is needed to obtain values of the 
turbulent viscosity.  There are several such equation sets that have been 
developed over the years to represent various turbulence models.  The set 
selected here is the Shear Stress Transport (SST) model [57].  In general, the 
applicability of one or the other turbulence model has to be confirmed by 
information from experimentation.  In this connection, the Shear Stress Transport 
(SST) model has received considerable support [58 – 61].  It represents a 
merging of two previously developed models, the k-ε and k-ω models.  The 
quantity k is the turbulence kinetic energy, ε is the turbulence dissipation, and ω 
is the turbulent eddy frequency.  The k-ε model has been demonstrated to give 
satisfactory descriptions ofy the velocity field at locations that are distant from 
bounding walls, and the k-ω model provides a good characterization of velocities 
in the near neighborhood of the wall.  
 
A third set of equations was created to provide a means of dampening the 
turbulence kinetic energy predicted by the SST model [62, 63].  The dampening 
functions to diminish turbulence in the intermittent regime that is the transition 
between laminar and turbulent.  A further functioning of the dampening is to 
suppress turbulence altogether in order to achieve purely laminar flow.  The SST-
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based dampening model is the only one that has been specifically adapted to 
internal flows.   
 
The starting point of the analysis is the RANS generalization of the Navier-Stokes 
equations.  These equations, as used here, are 








































As written, these equations are applicable for incompressible flow with constant 










The Reynolds stresses are represented in Eq. (4.2) by the turbulent viscosity 
μturb.   
 
 






















































































2 112  (4.5) 
 
The solution of Eqs. (4.4) and (4.5) yields the values of k and ω, which give the 




















































































The nomenclature that appears in Eqs. (4.2) – (4.8) is: 
 
A model constant 
Eγ1, Eγ2 intermittency destruction terms 
F1, F2 blending functions in the SST model 
Pk production term for the turbulent kinetic energy 
Pγ1, Pγ2 intermittency production terms 
PΠ,t production term for the transition onset Reynolds number 
S absolute value of the shear strain rate 
u local velocity 
xi tensor coordinate direction 
α SST model constant 
β1, β2 SST model constants 
ω turbulent eddy frequency 
µ molecular viscosity 
µturb turbulent viscosity 
σ Prandtl-number-like diffusion coefficient 
γ damping factor 
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ρ fluid density 
Π turbulent adjunct function 
 
It is relevant to discuss the manner in which the turbulence is damped.  In that 
regard, reference may be made to Eq. (4.4), and, in particular, to the term 
involving Pk which represents the rate of production of turbulence kinetic energy.  
In the native form of Eq. (4.4), the multiplying factor γ does not appear.  It is only 
when the total model of turbulence that includes intermittency and laminarization 
that γ is employed.  It is, in fact, a damping factor which diminishes the rate of 
turbulence production. 
 
These partial differential equations were discretized by means of finite-volume 
method.  The discretization is performed within the software selected for effecting 
the solution.  The chosen software package uses a unique solution algorithm.  
That algorithm can be characterized as the false-transient method. 
 
To facilitate the discussion of that method, it is relevant to recall that any set of 
differential equations having time-independent boundary conditions will converge 
to a steady-state solution regardless of the initial conditions.  A good example is 
the unsteady heat conduction equation.  To solve that equation requires 
knowledge of ρ, c, and k.  On the other hand, the solution to the steady-state 
conduction equation requires knowledge only of k.  If the solution algorithm for 
attainment of steady-state results is phrased as a transient, then convenient false 
values of ρ and c can be assigned to accelerate the transient solution.  The 
correct steady-state solution will be obtained regardless of the selected values of 
ρ and c.  It has been demonstrated that for many types of problems, the false-
transient approach will lead to a converged steady-state solution more rapidly 
than the more familiar iterative approach. 
 
To obtain a steady-state solution for the three dimensional problem, a solution 
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domain was selected which encompassed the spaces through which fluid 
passed.  That domain was bounded by solid walls except at the inlet and exit 
cross sections.  The meshing of the solution domain is a critical activity.  It was 
based on having high mesh densities in regions of high velocity gradients.  
Approximately five million nodes were employed.  An accepted metric used to 
assess the sufficiency of a mesh is the value of y+ at wall-adjacent nodes.  It is 
accepted in the numerical simulation community that a value of y+ of one is a 
characteristic of an excellent mesh.  For the present calculations, the largest 
encountered value of y+ at the impingement surfaces of the collection modules 
was approximately 0.3.  On this basis, it is believed that the mesh is satisfactory. 
 
The specification of the boundary conditions is a critical aspect of the problem 
description.  The solution was formulated as a mass-flow driven flow.  This 
means that the mass flow rate was specified at the downstream end of the 
solution domain, from which the flow exited.  The other bounding surfaces of the 
solution domain were specified as walls with the no-slip condition.  Heat transfer 
was not included in any part of this model. 
 
Convergence was monitored by one or two metrics.  One of these was the 
attainment of residuals on the order of 10-6.  The other metric was to monitor the 
progression of the key results as the solution progressed with accumulating 
iterations.  Convergence was indicated when these key results ceased to change 




RESULTS AND DISCUSSION 
The results of this investigation encompass a broad range of significant 
information.  Of immediate utility with regard to applications is the collection 
capability of the various zones that constitute the succession of targets.  An 
understanding of this quantitative information rests upon knowledge of the 
patterns of fluid flow and the trajectories of the particles.  The presentation of 
results will follow the sequence that has been described in the preceding 
sentences. 
PARTICLE COLLECTION IN VARIOUS ZONES 
The following table describes the percentage of each particle size captured in the 
various collection zones. 
Table 4.1 – Particle capture in the various collection zones 
 Collection Zones  
Particle 
Size 
First Second Third Fourth Fifth TOTAL 
13 µm 100% 0% 0% 0% 0% 100% 
8 µm 74% 26% 0% 0% 0% 100% 
5 µm 1% 97% 2% 0% 0% 100% 
3.1 µm 1% 36% 62% 0% 0% 100% 
1.8 µm 0% 0% 0% 0% 0% 0% 
 
Inspection of the table displays the distribution of capture for particles of different 
sizes.  The largest among the particles, 13 µm, are very effectively captured in 
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the first zone.  On the other hand, the 8-µm particles are distributed among 
zones one and two, with the lion’s share being collected in the first zone.  The 
third particle size, 5 µm, is very efficiently trapped in the second zone.  The 
spread-mode of collection is in evidence for the fourth particle size, 3.1 µm.  The 
fifth size, 1.8 µm, passed through the system without being collected in any zone.   
The results conveyed in Table 4.1 provide clear evidence that the developed 
methodology is capable of determining where particles of difference sizes are 
deposited. This outcome warrants comparison with the original objective of the 
work.  That goal was to develop a methodology for predicting the trajectories of 
therapeutic particulates ingested through the mouth or nose and passing through 
the respiratory system en route to targets in the lungs.  The methodology had to 
be capable of dealing with a flow path of extraordinary complexity.  It is believed 
that the modeled flow path (Figure 4.4) fulfills the complexity requirement.  The 
displayed capability of the methodology to quantify the trajectories of the particles 
and to predict their zones of termination is clear testimony to the fulfillment of the 
enunciated goal.  
 
FLUID FLOW PATTERNS 
The solution domain used in these simulations contains a very complex network 
of abrupt changes of direction and highly variable flow-passage cross sections.  
Such intricate geometries often produce regions of steep pressure gradients and 
zones of flow separation.  These features will give rise to non-uniform patterns of 
fluid flow throughout the system. 
The presentation of fluid flow information begins with a focus on the inlet and the 
first collection zone, and Figure 4.8 has been prepared for this purpose.  This 
figure is a color-contour diagram projected on a vertical plane cut through the 
center of the flow passage.  The colors correspond to velocity magnitudes which 
are keyed to the legend at the upper left of the figure.  The inlet section of the 
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flow path displays a variety of colors revealing regions of flow acceleration and 
flow separation.  Owing to the convergence at the end of the inlet section, a high 
velocity, jet-like flow enters the first collection module.  The jet impinges on the 
base of the collection zone and splashes radially outward.  The spread is 
arrested by the vertical end walls, causing the flow to fold back on itself. 
 
Figure 4.8 – Velocity contour diagram of inlet section and first collection zone 
An alternative display of the fluid flow pattern in the initial portion of the system is 
by means of streamlines which are conveyed in Figure 4.9.  The figure shows the 
convergence that spawns the strong jet at the lower end of the inlet section.  The 
jet splash identified in the foregoing is readily observed.  Note, however, that the 
jet splash and spread is not axisymmetric because the port through which the 
flow exits from the collection zone is situated unsymmetrically as can be seen in 
the figure.  The streamlines converge at the exit port and pass into a bridge-like 
channel en route to the second collection zone.  
Further examination of Figure 4.9 shows a non-symmetrical distribution of airflow 
streamlines through the assembly.  A limited number of streamlines are shown in 
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the figure to preserve clarity.  The walls of the solution domain are shown in a 
light blue color to assist in visualizing the geometry while still being able to see 
the streamlines within. 
 
Figure 4.9 – Streamline pattern in the initial portion of the flow system 
Further information about the flow pattern in the initial portion of the system can 
be obtained from Figure 4.10.  This figure deals with the same portion of the 
system as was the focus of Figure 4.9 but the same space is viewed from a 
different vantage point.  The main message of Figure 4.10 is the strong bias in 




Figure 4.10 – Alternative view of the streamline pattern in the initial portion of the 
flow system 
The nature of the flow through the passageways that interconnect the successive 
collection modules is illustrated in Figure 4.11.  In particular, the pictured 
passageway interconnects the second and third modules.  In addition, the figure 
shows the internal structure of the latter. The passage delivers the flow to the 
upper portion of the collection module.  The delivered flow enters a plenum-like 
manifold.  The bottom wall of the plenum is a perforated plate whose function is 
to spread the flow more or less uniformly as it enters the lower section of the 
collection module.  The actual collection occurs at the lower surface of that 
section.  Those particles that are not collected pass out of the zone and continue 
on to the next. 
Close examination of the flow streamlines entering the collection zone reveals 
the presence of a swirl, or rotational component to the flow, demonstrating further 
 
Inlet 




Figure 4.11 – View of the connecting passageway to the third collection zone 
and the internal structure of the module 
complexity in the system.  This swirl component can be seen by looking at the 
connecting passageways between any two collection modules in a manner 
similar to that of Figure 4.11. 
More insights into the complexity of the flow system can be obtained by 
inspection of the internal structure of still another collection module, the fifth, 
which is shown in Figure 12.  The direction of observation for the viewing of 
Figure 12 was chosen to reveal details that could not be easily seen in Figure 11.  
The flow is delivered to the plenum-type distribution manifold which constitutes 
the upper portion of the collection module.   Clearly visible in the figure is the 
surface of the perforated plate which bounds the manifold from below.  Of 
particular note is the very large number of holes which constitute the 
perforations.  Clearly, by comparison of Figures 4.11 and 4.12, the number of 
perforation holes increases from one collection module to the next.  
Consequently, there is a concomitant increase of the complexity of the flow 
system geometry.  








Figure 4.12 – Details of the fifth collection zone revealing flow system 
complexities 
number of streamlines present.  This figure makes the non-uniform velocity 
distribution more visible.  It can be seen that the momentum carries the flow from 
the left side into the lower right portion (as viewed in the figure) of the collection 
zone, leaving a comparatively small amount of flow in the left section of the zone.  
The flow continues its bias as it progresses toward the exit port located at the top 
of the figure. 
A vivid display of the flow produced by the multi-hole perforated plate of the fifth 
module is displayed in Figure 4.13, which is a velocity contour diagram that has 
been projected onto a vertical plane cut through the diameter of the plate.  The 
jets created by the flow exiting the individual perforation holes are sharply 
etched.  Although the jet velocities exiting the holes are as great as 20 m/s, there 




Figure 4.13 – Velocity contour diagram in a vertical plane cut through the 
perforated distribution plate of the fifth collection zone 
 
Figure 4.14 is the final figure conveying the air flow patterns.  The figure displays 
the streamlines which trace the air flow from its origins to its exit from the system.  
An overall appraisal of the figure is very convincing of both the small-scale and 
the large-scale geometric complexity experienced by the flowing air.  This level of 




Figure 4.14 – Airflow streamlines through the entire system 
 
PARTICLE MOTION 
As previously discussed, particle impactors are designed to separate particles 
from a carrier fluid stream based on their relative sizes.  The size of particle that 
will be collected in any particular collection zone will depend not only on the size 
and mass of the particle, but also on the flow pattern of the airflow in the specific 
zone and the distance from the exit of the jet to the bottom target surface.  The 
first demonstration of particle motion is displayed in Figure 4.15.  The figure 
shows the paths, indicated by lines of varying shades of blue, of 100 of the 
largest, 13-µm diameter, particles passing through the system.  In this example, 





Figure 4.15 – Lines showing the paths of 13 µm particles all collecting in the first 
zone 
termination is indicated in the figure by the blue lines coming to an end on the 
bottom surface of the zone, an outcome that was previously introduced in Table 
4.1.  Note that the paths of the particles seen in the figure are reminiscent of the 
previously exhibited streamlines of the airflow. 
An alternative method of examining the spatial distribution of collected particles is 
shown in Figure 4.16.  The figure illustrates the collection pattern of the 13-µm 
particles as they impacted the bottom surface of the first collection zone.  The 
negative values shown in the legend to the left of the diagram are an indication of 
the positive direction of the coordinate system relative to the direction of the 
particles at time of impact.  The deployment of the collected particles is not 





Figure 4.16 – A view from the bottom of the first collection zone showing the 
pattern of 13 µm particle deposition locations 
Table 4.1 indicated that some of the 8-µm particles were collected in the first 
module as well as in the second module.  Figure 4.17 is presented to illustrate a 
sample of the 8- µm particles that are respectively collected particles in these 
zones.  The figure contains red circles to draw attention to some of the particles 
that were collected.  Examination of the figure reveals that some of the particles 
stop in the first collection zone while many other particles can be seen leaving 
the first zone and continuing through the connecting passageway to the second 
collection zone.  It can be seen that several particles stop in the second 





Figure 4.17 – Path of 8-µm particles through the first two collection zones.  Red 
circles indicate particle(s) that stopped and were collected in the respective zone. 
Figure 4.18 is presented to show, in a manner similar to Figure 4.16, where the 
8-µm particles were collected on the bottoms of the first and second zones.  It 
can be seen from Figure 4.18 that none of the 8 µm particles were collected in 
the third zone, which appears in the bottom of the figure.  This agrees with the 
data in Table 4.1 which indicated that there were not any 8-µm particles collected 
in zones three, four, or five. 
To supplement the results shown in Figs. 4.8-4.18, Table 4.2 is presented to 
provide additional quantitative data to describe the particle motion.  The 
information shown in the table represents average travel time and distance for all 






Figure 4.18 – View of the bottom of the first and second collection zones.  The 
blue color represents the highest density of particles, followed by green, yellow 
and then orange. 
example, Table 4.1 and Figure 4.15 indicated that all of the 13-µm particles were 
collected in the first zone, while all other particle sizes continued further into the 
system.  It would be expected then, that these particles would have the shortest 
average traveling time and distance, as indicated in Table 4.2. 
  
First zone 
Second zone Third zone 
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13 µm 14.0 0.092 
8 µm 24.0 0.221 
5 µm 36.7 0.321 
3.1 µm 42.5 0.366 






Medical treatment by means of inhalation of various nebulized drugs is a 
therapeutic modality being used to relieve patients of an increasing number of 
conditions.  The drugs may take the form of small liquid droplets or particles and 
may be inhaled through the nose or the mouth.  The efficacy of the treatment is 
highly dependent on the successful deposition of the drug at its intended target.  
The mechanism of drug delivery can be understood by study of particle transport 
theory. 
Specifically, in this work, well-documented modalities in the field of particle 
impaction have served as guidance.  Particle impaction theory dictates that when 
detailed knowledge of the carrier fluid motion is available, along with the size and 
mass of the particles of interest, it is possible to predict where the particles will be 
deposited with reasonable accuracy.  Inertial impactors are a common and 
effective use of this technology in industry.  In that instance, the fluid flow can be 
designed to give the specific characteristics that yield the desired separation of 
particles. 
In the case of the human respiratory system, the fluid flow domain is not well 
defined or able to be specified.  Additionally, it contains many features that create 
highly complex flows.  These complexities make it increasingly difficult to 
accurately predict where particles might land and therefore produce challenges in 
achieving effective therapeutic results.  Furthermore, particles of different size 
and mass will collect in different zones throughout the system.  Owing to the fact 
that inhaled medications in the form of particles are often not necessarily of the 
same size, this reality produces further complications in getting the drug to the 
intended targets.  Another significant variable presents itself since individual 
patients have different breathing patterns and speed of inhalation.  These 




The work performed here demonstrates the capability and methodology that 
could be used to improve the design and efficacy of inhaled pharmaceuticals.  
The research of current literature revealed that models of the physical geometry 
of the human respiratory system can be obtained.  It would be expected that this 
geometry would vary between patients, and this variability could be used as one 
element of a parametric study which would include particle size and mass, along 
with various air flow velocities and patterns.  A series of CFD simulations could 
then be conducted which would optimize the particle size and mass with respect 
to the expected variability due to geometry and air flow velocities observed in a 
representative sample of patients.  Benefits of such an approach could include 
higher treatment success rates, lower levels of ingested drugs required, reduced 





The work described herein discussed, in detail, several modalities of delivering 
therapeutic drugs to the human body utilizing a multiplicity of transport processes 
indigenous to mechanical engineering.  Specifically, fluid mechanics and mass 
transfer formed the basis of a model to understand the delivery of a drug that is 
placed on a stent to reduce the rate of restenosis due to the patient’s tissue 
rejecting the foreign device.  The second investigated topic provided the 
fundamental underpinning for a novel non-surgical treatment option for 
menorrhagia by utilizing heat transfer, fluid mechanics, and phase change 
theory.  The final chapter integrated fluid mechanic and particle transport theory 
to create a methodology for simulating the delivery of a pharmaceutical drug in 
particle form through the human respiratory system.  
Atherosclerosis is a disease characterized by the buildup of plaque on the artery 
wall, thereby reducing the effective cross section of the lumen.  This reduction of 
flow cross section creates additional pressure drop in the cardiovascular system 
and ultimately puts greater stress on the heart.  Ultimately, portions of the plaque 
may break free and cause significant blockages downstream, resulting in a 
stroke or other more significant medical emergencies.  A common treatment for 
this condition is to place a stent into the artery after an angioplasty to hold the 
artery walls in an open condition.  It is found in many cases that after some time, 
the body rejects the stent and the tissue swells around the stent and creates 
another flow blockage.  To help increase the probability of the body accepting the 
stent, it has become common to coat the stent with a drug which reduces 
inflammation in the artery walls.  When the drug-coated stent is in place in the 
lumen, the drug can be transferred into the flowing blood by advection or into the 
artery walls via diffusion.  Drug that transfers into the blood is carried away and is 
not useful in reducing any stent-induced inflammation of the artery walls.  For this 
reason, it is important to understand and quantify what portion of the drug will 
diffuse into the tissue and what part is unavailable.  This information can guide 
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the design of the stent and the amount of drug for a more effective result in the 
patient.  The work described here provided a complete model to understand what 
portion of the drug transferred to the intended areas and what portion was lost 
into the flowing blood in the lumen.  Further, the model was formulated in a 
universal fashion by transforming it into a dimensionless form.  This form proves 
to be of great value as it allows for quick study of many different classes of 
problems with a single set of solutions. 
Menorrhagia is a condition that affects a significant percent of the female 
population.  The traditional remedies typically consisted of removal of all or part 
of the uterus.  The quest for other less invasive treatments is easily understood 
and appreciated.  A newly proposed treatment option having great promise 
utilizes condensing steam to provide adequate heat to achieve necrosis of the 
uterine lining.  For this treatment to become an increasingly viable alternative, it 
is imperative to have a clear understanding of the effect of treatment duration on 
the depths and uniformity of tissue necrosis in the uterus.  The created numerical 
simulation model auto-regulated the rate of vapor delivery to the uterine surface 
for subsequent condensation and thermal energy liberation.  The model also 
included the most current understanding published in the literature of bioheat 
transfer as well as of the tissue damage integral.  The results clearly showed 
close agreement with experimental results and highlighted the importance of 
calculating the tissue damage that occurs after termination of the application of 
steam; in particular,   the necrosis depths found in the simulation also closely 
matched the non-uniform nature shown in the experimental results.  The here-
created simulation tools can now be used to further understand and develop a 
treatment modality that has significant advantages for the patient than more 
invasive options. 
The utilization of medications which are administered by inhalation, either 
through the nose or mouth, is ever increasing.  In many cases, the drug is 
presented in the form of small particles which are carried into the respiratory 
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system as the patient inhales.  The effectiveness of the medication is influenced 
by obtaining the proper amount arriving at the targeted sites.  The path that the 
particle-laden air flow must follow is of great complexity and gives rise to many 
opportunities for particles to be deposited in places other than the intended 
targets.  It appears that there presently does not exist any predictions of air-
carried particle trajectories through flow passages having complexities 
comparable to those encountered in the respiratory system. 
This recognition motivated the third focus of this research.  A model problem 
having flow-passage complexities comparable to those of the respiratory system 
was selected for the task of methodology development.  The selected model 
problem is known to particle-technology practitioners and offers the advantage of 
known geometry. 
The methodology developed here is built on concepts indigenous to particle 
transport theory and to particle capture by inertial impactors.  The methodology 
was implemented by detailed numerical-simulation solutions of the model 
problem.  The particle-laden airflow encompassed a range of particle sizes.  The 
distribution of particle sizes in the several serially deployed collection zones 
demonstrated the target-reaching attributes of different sized particles.   
The developed methodology could be used to track the trajectories and 
deposition sites of different size particles through various respiratory system 
geometries.  A sensitivity analysis could be performed to quantify the amount of 
variability in particle deposition due to uncontrollable patient-specific factors.  
This capability could enable optimizing the drug particle size and mass based on 
the intended targets of the medication and lead to much more effective treatment 
for the patient with a reduction of the chances of complications, discomfort, and 
costs. 
The work performed in this research illustrates how, with the ever-increasing 
capabilities of numerical simulation, biomedical therapies can be enhanced and 
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made more effective.  By synergistic use of numerical simulation and clinical 
studies, new biomedical devices can be developed in shorter durations and 





[1] V. Bush, The differential analyzer. A new machine for solving differential 
equations, Journal of the Franklin Institute 212 (4) (1931) 447–488. 
[2] S. Zarek MD, H. Sharp MD, Global endometrial ablation devices, Clinical 
Obstetrics and gynecology 51(1) 2008 167-175. 
[3] R. Mongrain, I. Faik, R. Leask, J. Rodés-Cabau, É. Larose, O. Bertrand, 
Effects of diffusion coefficients and struts apposition using numerical 
simulations for drug eluting coronary stents, J. Biomech. Eng. 129 (2007) 
733-742. 
[4] P. Zunino, C.  ’Angelo, L. Petrini, C. Vergara, C. Capelli, F. Migliavacca, 
Numerical simulation of drug eluting coronary stents: Mechanics, fluid 
dynamics and drug release, Comput. Method. Appl. M. 198 (2009) 3633-
3644. 
[5] G. Vairo, M. Cioffi, R. Cottone, G. Dubini, F. Migliavacca, Drug release 
from coronary eluting stents: A multidomain approach, J. Biomech. 43 
(2010) 1580-1589. 
[6] C. Hwang, D. Wu, E. Edelman, Physiology transport forces govern drug 
distribution for stent-based delivery, Circulation (2001) 600-605. 
[7] G. Pontrelli, F. de Monte, Modeling of mass dynamics in arterial drug-
eluting stents, J. Porous Media 12(1) (2008) 19-28. 
[8] G. Pontrelli, F. de Monte, Mass diffusion through two-layer porous media: 
an application to the drug-eluting stent, Int. J. Heat Mass. Tran. 50 (2007) 
3658-3669. 
[9] P. Zunino, Multidimensional pharmacokinetic models applied to the design 
of drug-eluting stents, Cardiovasc. Eng. 4(2) (2004) 181-191. 
101 
 
[10] M. Grassi, G. Pontrelli, L. Teresi, G. Grassi, L. Comel, A. Ferluga, L. 
Galasso, Novel design of drug delivery in stented arteries: A numerical 
comparative study, Math. Biosci. Eng. 6(3) (2009) 493-508. 
[11] G. Pontrelli, F. de Monte, A multi-layer porous wall model for coronary 
drug-eluting stents, Int. J. Heat Mass Transf. 53 (2010) 3629-3637. 
[12] B. O’Connel, M. Walsh,  emonstrating the influence of compression on 
artery wall mass transport, Ann. of Biomed. Eng. 38 (4) (2010) 1354-1366. 
[13] B. O’Connel, T. McGloughlin, M. Walsh, Factors that affect mass transport 
from drug eluting stents into the artery wall, Biomed. Eng. Online (2010) 
9:15. 
[14] D. Sakharov, L. Kalachev, D. Rijken, Numerical simulation of local 
pharmacokinetics of a drug after intravascular delivery with an eluting 
stent, J. Drug Target. 10 (6) (2002) 507-513. 
[15] C. Vergara, P. Zunino, Multiscale boundary conditions for drug release 
from cardiovascular stents, Multiscale Model. Sim. 7(2) (2008) 565-588. 
[16] S. Rugonyi, Effect of blood flow on near-the-wall mass transport of drugs 
and other bioactive agents: A simple formula to estimate boundary layer 
concentrations, J. Biomech. Eng. 130 (2008) 021010-1 – 021010-7. 
[17] Wikipedia, http://en.wikipedia.org/wiki/Menorrhagia, 2013. 
[18] D. Hill, P. Maher, Intrauterine surgery using electrocautery, Australian and 
New Zealand Journal of Obstetrics and Gynaecology 30 (2) (1990) 145-
146. 
[19] H. T. Sharp, Assessment of new technology in the treatment of idiopathic 
menorrhagia and uterine leiomyomata, Obstetrics and Gynecology 108 (4) 
(2006) 990-1003. 




[21] S. M. van der Kooij, W. M. Ankum, W. J. K. Hehenkamp, Review of 
nonsurgical/minimally invasive treatments for uterine fibroids, Curr Opin 
Obstet Gynecol 24 (6) 2012 368-375. 
[22] S. Yeasmin, K. Nakayama, M. Ishibashi, A. Katagiri, K. Iida, N. 
Nakayama, S. Aoki, Y. Kanaoka, K. Miyazaki, Microwave endometrial 
ablation as an alternative to hysterectomy for the emergent control of 
uterine bleeding in patients who are poor surgical candidates, Gynecology 
and obstetrics, 280 (2) 2009 279-282. 
[23] B. Feldberg, N. J. Cronin, A 9.2 GHz microwave applicator for the 
treatment of menorrhagia, IEEE MTT-S Digest (1998) 755-758. 
[24] E. Downes, R. Yasmin, R. Flemming, Microwave endometrial ablation: 
Development and clinical application, Surgical Technology International, 
16 (2007) 142-146. 
[25] Hong WK. American Association for Cancer Research. Cancer Medicine, 
8th Ed. Shelton, Conn.: People's Medical Pub. House; 2010. 
[26] Dewhirst MW, Viglianti BL, Lora-Michiels M, Hanson M, Hoopes PJ. Basic 
principles of thermal dosimetry and thermal thresholds for tissue damage 
from hyperthermia. Int J Hyperthermia 19 (3) (2003) 267-294. 
[27] Pearce JA, Thomsen S. Kinetic models of laser-tissue fusion processes. 
Biomed Sci Instrum 29 (1993) 355-360. 
[28] McMurray T, Pearce JA. Thermal damage quantification utilizing tissue 
birefringence color image analysis. Biomed Sci Instrum 29 (1993) 235-
242. 
[29] Dewhirst MW, Lora-Michiels M, Viglianti BL, Dewey WC, Repacholi M. 
Carcinogenic effects of hyperthermia. Int J Hyperthermia 19 (3) (2003) 
236-251. 
[30] Yarmolenko PS, Moon EJ, Landon C, Manzoor A, Hochman DW, Viglianti 
BL, Dewhirst MW. Thresholds for thermal damage to normal tissues: an 
update. Int J Hyperthermia 27 (4) (2011) 320-343. 
103 
 
[31] Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. 
International journal of radiation oncology, biology, physics 10 (6) (1984) 
787-800. 
[32] Lepock JR. Cellular effects of hyperthermia: relevance to the minimum 
dose for thermal damage. International Journal Of Hyperthermia 19 (3) 
(2003) 252-266. 
[33] K. Diller, J. Valvano, J. Pearce, (2000). Bioheat Transfer. In: F. Kreith 
(Ed.)  CRC Handbook of Thermal Engineering (4-114 – 4-188). Boca 
Raton: CRC Press LLC. 
[34] Arrhenius S. Uber die Reaktionsgeschwindigkeit bei der Inversion von 
Rohrzucker durch Sauren (On the Reaction Rate in the Inversion of Cane 
Sugar by Acids). Z Phys Chem 4 (1889) 226-248. 
[35] Arrhenius S. Quantitative Laws in Biological Chemistry. London: G. Bell & 
Sons; 1915. 184 p. 
[36] Johnson FH, Eyring H, Stover BJ. The Theory of Rate Processes In 
Biology and Medicine. New York: John Wiley & Sons; 1974. 
[37] Eyring H. The Energy of Activation for Bimolecular Reactions Involving 
Hydrogen and the Halogens, According to Quantum Mechanics. Journal of 
the American Chemical Society, 53 (1931) 2537-2549. 
[38] Eyring H. The Activated Complex in Chemical Reactions. Journal of 
Chemical Physics 3 (2) (1935) 107-115. 
[39] Eyring H, Polyani M. Über Einfache Gasreaktionen  (On Simple Gas 
Reactions). Zeitschrift fur Physikalische Chemie B 12 (1931) 279-311. 
[40] Polyani M. Atomic Reactions. London: Williams - Norgate; 1932. 
[41] J. A. Pearce, Relationship between Arrhenius models of thermal damage 
and the CEM 43 thermal dose. Energy-based Treatment of Tissue and 
Assessment V. Volume 7181. San Jose, CA, United States: SPIE, P.O. 




[42] J. Olsrud, B. Friberg, M. Ahlgren, B. R. R. Persson, Thermal conductivity 
of uterine tissue in vitro, Phys. Med. Biol., 43 (1998) 2397-2406. 
[43] IT’IS Foundation website, http://www.itis.ethz.ch/itis-for-health/tissue-
properties/database/thermal-conductivity/. 
[44] Balasubramaniam, T. A., H. F. Bowman, Thermal conductivity and thermal 
diffusivity of biomaterials: A simultaneous measurement technique, J. 
Biomech. Engr. 99 (1977) 148-154. 
[45] M. L. Cohen, Measurement of the thermal properties of human skin, A 
review, J. Invest. Dermatol, 69 (1977) 333-338. 
[46] H. Pennes, Analysis of tissue and arterial blood temperatures in the 
resting human forearm, J. Appl. Physiol. 85 (1948) 5-34. 
[47] J. P. Abraham, E. M. Sparrow, A thermal-ablation bioheat model including 
liquid-to-vapor phase change, pressure- and necrosis-dependent 
perfusion, and moisture-dependent properties, Int. J. Heat Mass Transf. 
50 (2007) 2537-2544. 
[48] Personal communication, Aegea Medical, 1/13/13. 
[49] K. Chin, N. Mulchan, S. Hong, S. Yoon, BEE 4530, Computer aided 
engineering: Applications to biomedical processes, Final report. 
[50] P. W. Longest, M. Hindle, S. D. Choudhuri, Effects of generation time on 
spray aerosol transport and deposition in models of the mouth-throat 
geometry, Journal of aerosol medicine and pulmonary drug delivery, 22 
(2) (2009) 67-83. 
[51] J. Sandeau, I. Katz, R. Fodil, B. Louis, G. Apiou-Sbirlea, G. Caillibotte, D. 
Isabey, CFD simulation of particle deposition in a reconstructed human 
oral extrathoracic airway for air and helium-oxygen mixtures, Journal of 
aerosol science, 41 (2010) 281-294. 
105 
 
[52] C-L. Lin, M. H. Tawhai, E. A. Hoffman, Multiscale image-based modeling 
and simulation of gas flow and particle transport in the human lungs, 
WIREs Syst Biol Med 2013, 5:643–655. doi: 10.1002/wsbm. 1234. 
[53] P. Roth, C. F. Lange, W. H. Finlay, The effect of breathing pattern on 
nebulizer drug delivery, Journal of aerosol medicine, 16 (3) (2003) 325-
329. 
[54] J. Heyder, M. Svartengren, (2002). Basic Principles of particle behavior in 
the human respiratory tract. In: H. Bisgaard, C. O’Callaghan, G. Smaldone 
(Eds.) Drug delivery to the lung (21-45). New York: Marcel Dekker. 
[55] V. A. Marple, K. Willeke, (1976). Inertial impactors: Theory, design and 
use. In Y. H. Liu (Ed.) Fine Particles, Aerosol Generation, Measurement, 
Sampling, and Analysis (411-446). Academic Press, Inc. 
[56] C. J. Reagle, J. M. Delimont, W. F. Ng, S. V. Ekkad, V. P. Rajendran, 
Measuring the coefficient of restitution of high speed microparticle impacts 
using a PTV and CFD hybrid technique, Measurement science and 
technology, 24 (2013) 1-11. 
[57] F. Menter, Two-equation eddy-viscosity turbulence models for engineering 
applications, AIAA J 30 (1994) 1598-1605. 
[58] E. Sparrow, J. Gorman, J. Abraham, Quantitative assessment of the 
overall heat transfer coefficient U, Journal of heat transfer, 135 (2013) 
61102-1 – 61102-7. 
[59] J. Abraham, E. Sparrow, J. Tong, Heat transfer in all pipe flow regimes: 
laminar, transitional/intermittent, and turbulent, International Journal of 
Heat and Mass Transfer, 52 (2009) 557-563. 
[60] J. Stark, J. Gorman, M. Hennessey, F. Reseghetti, J. Willis, J. Lyman, J. 
Abraham, M. Borghini, A computational method for determining XBT 
depths, Ocean Science, 7 (2011) 733-743. 
[61] J. Abraham, J. Gorman, F. Reseghetti, E. Sparrow, W. Minkowycz, Drag 
coefficients for rotating expendable bathythermographs and the impact of 
106 
 
launch parameters on depth predictions, Numerical Heat Transfer, Part A, 
62 (2012) 25-43. 
[62] F. Menter R.B. Langtry, S.R. Likki, Y.B. Suzen, P.G. Huang, S. Volker, A 
correlation-based transition model using local variables – part 1: model 
formulation, J. Turbomachinery 129 (2006) 413-422. 
[63] R.B. Langtry, F. Menter, S.R. Likki, Y.B.Suzen, P.G. Huang, S. Volker, A 
correlation-based transition model using local variables – part 2: test 
cases and industrial applications, J. Turbomachinery 128 (2006) 423-434. 
 
